id	sid	tid	token	lemma	pos
cord-258416-1jrbu8ox	1	1	key	key	JJ
cord-258416-1jrbu8ox	1	2	:	:	:
cord-258416-1jrbu8ox	1	3	cord-258416	cord-258416	NNP
cord-258416-1jrbu8ox	1	4	-	-	HYPH
cord-258416-1jrbu8ox	1	5	1jrbu8ox	1jrbu8ox	CD
cord-258416-1jrbu8ox	1	6	authors	author	NNS
cord-258416-1jrbu8ox	1	7	:	:	:
cord-258416-1jrbu8ox	1	8	Drenovska	Drenovska	NNP
cord-258416-1jrbu8ox	1	9	,	,	,
cord-258416-1jrbu8ox	1	10	Kossara	Kossara	NNP
cord-258416-1jrbu8ox	1	11	;	;	:
cord-258416-1jrbu8ox	1	12	Schmidt	Schmidt	NNP
cord-258416-1jrbu8ox	1	13	,	,	,
cord-258416-1jrbu8ox	1	14	Enno	Enno	NNP
cord-258416-1jrbu8ox	1	15	;	;	:
cord-258416-1jrbu8ox	1	16	Vassileva	Vassileva	NNP
cord-258416-1jrbu8ox	1	17	,	,	,
cord-258416-1jrbu8ox	1	18	Snejina	Snejina	NNP
cord-258416-1jrbu8ox	1	19	title	title	NN
cord-258416-1jrbu8ox	1	20	:	:	:
cord-258416-1jrbu8ox	1	21	Covid‐19	covid‐19	JJ
cord-258416-1jrbu8ox	1	22	pandemic	pandemic	NN
cord-258416-1jrbu8ox	1	23	and	and	CC
cord-258416-1jrbu8ox	1	24	the	the	DT
cord-258416-1jrbu8ox	1	25	skin	skin	NN
cord-258416-1jrbu8ox	1	26	date	date	NN
cord-258416-1jrbu8ox	1	27	:	:	:
cord-258416-1jrbu8ox	1	28	2020	2020	CD
cord-258416-1jrbu8ox	1	29	-	-	HYPH
cord-258416-1jrbu8ox	1	30	09	09	CD
cord-258416-1jrbu8ox	1	31	-	-	SYM
cord-258416-1jrbu8ox	1	32	21	21	CD
cord-258416-1jrbu8ox	1	33	journal	journal	NN
cord-258416-1jrbu8ox	1	34	:	:	:
cord-258416-1jrbu8ox	1	35	Int	Int	NNP
cord-258416-1jrbu8ox	1	36	J	J	NNP
cord-258416-1jrbu8ox	1	37	Dermatol	Dermatol	NNP
cord-258416-1jrbu8ox	1	38	DOI	doi	NN
cord-258416-1jrbu8ox	1	39	:	:	:
cord-258416-1jrbu8ox	2	1	10.1111	10.1111	CD
cord-258416-1jrbu8ox	2	2	/	/	SYM
cord-258416-1jrbu8ox	2	3	ijd.15189	ijd.15189	NN
cord-258416-1jrbu8ox	3	1	sha	sha	NNP
cord-258416-1jrbu8ox	3	2	:	:	:
cord-258416-1jrbu8ox	4	1	b71d4e362ccc1afbef595c2ca56847de1adf8128	b71d4e362ccc1afbef595c2ca56847de1adf8128	IN
cord-258416-1jrbu8ox	4	2	doc_id	doc_id	CD
cord-258416-1jrbu8ox	4	3	:	:	:
cord-258416-1jrbu8ox	5	1	258416	258416	CD
cord-258416-1jrbu8ox	5	2	cord_uid	cord_uid	NNS
cord-258416-1jrbu8ox	5	3	:	:	:
cord-258416-1jrbu8ox	5	4	1jrbu8ox	1jrbu8ox	CD
cord-258416-1jrbu8ox	6	1	In	in	IN
cord-258416-1jrbu8ox	6	2	the	the	DT
cord-258416-1jrbu8ox	6	3	beginning	beginning	NN
cord-258416-1jrbu8ox	6	4	of	of	IN
cord-258416-1jrbu8ox	6	5	the	the	DT
cord-258416-1jrbu8ox	6	6	COVID‐19	COVID‐19	NNP
cord-258416-1jrbu8ox	6	7	outbreak	outbreak	NN
cord-258416-1jrbu8ox	6	8	,	,	,
cord-258416-1jrbu8ox	6	9	skin	skin	NN
cord-258416-1jrbu8ox	6	10	manifestations	manifestation	NNS
cord-258416-1jrbu8ox	6	11	,	,	,
cord-258416-1jrbu8ox	6	12	if	if	IN
cord-258416-1jrbu8ox	6	13	present	present	NN
cord-258416-1jrbu8ox	6	14	,	,	,
cord-258416-1jrbu8ox	6	15	were	be	VBD
cord-258416-1jrbu8ox	6	16	not	not	RB
cord-258416-1jrbu8ox	6	17	paid	pay	VBN
cord-258416-1jrbu8ox	6	18	enough	enough	JJ
cord-258416-1jrbu8ox	6	19	attention	attention	NN
cord-258416-1jrbu8ox	6	20	.	.	.
cord-258416-1jrbu8ox	7	1	Then	then	RB
cord-258416-1jrbu8ox	7	2	,	,	,
cord-258416-1jrbu8ox	7	3	the	the	DT
cord-258416-1jrbu8ox	7	4	focus	focus	NN
cord-258416-1jrbu8ox	7	5	moved	move	VBD
cord-258416-1jrbu8ox	7	6	toward	toward	IN
cord-258416-1jrbu8ox	7	7	the	the	DT
cord-258416-1jrbu8ox	7	8	impact	impact	NN
cord-258416-1jrbu8ox	7	9	of	of	IN
cord-258416-1jrbu8ox	7	10	the	the	DT
cord-258416-1jrbu8ox	7	11	prolonged	prolong	VBN
cord-258416-1jrbu8ox	7	12	use	use	NN
cord-258416-1jrbu8ox	7	13	of	of	IN
cord-258416-1jrbu8ox	7	14	personal	personal	JJ
cord-258416-1jrbu8ox	7	15	protective	protective	JJ
cord-258416-1jrbu8ox	7	16	measures	measure	NNS
cord-258416-1jrbu8ox	7	17	in	in	IN
cord-258416-1jrbu8ox	7	18	both	both	CC
cord-258416-1jrbu8ox	7	19	healthcare	healthcare	NN
cord-258416-1jrbu8ox	7	20	workers	worker	NNS
cord-258416-1jrbu8ox	7	21	and	and	CC
cord-258416-1jrbu8ox	7	22	patients	patient	NNS
cord-258416-1jrbu8ox	7	23	.	.	.
cord-258416-1jrbu8ox	8	1	In	in	IN
cord-258416-1jrbu8ox	8	2	the	the	DT
cord-258416-1jrbu8ox	8	3	meantime	meantime	NN
cord-258416-1jrbu8ox	8	4	,	,	,
cord-258416-1jrbu8ox	8	5	attention	attention	NN
cord-258416-1jrbu8ox	8	6	is	be	VBZ
cord-258416-1jrbu8ox	8	7	increasingly	increasingly	RB
cord-258416-1jrbu8ox	8	8	paid	pay	VBN
cord-258416-1jrbu8ox	8	9	to	to	IN
cord-258416-1jrbu8ox	8	10	dermatology	dermatology	NN
cord-258416-1jrbu8ox	8	11	as	as	IN
cord-258416-1jrbu8ox	8	12	a	a	DT
cord-258416-1jrbu8ox	8	13	result	result	NN
cord-258416-1jrbu8ox	8	14	of	of	IN
cord-258416-1jrbu8ox	8	15	the	the	DT
cord-258416-1jrbu8ox	8	16	concern	concern	NN
cord-258416-1jrbu8ox	8	17	for	for	IN
cord-258416-1jrbu8ox	8	18	certain	certain	JJ
cord-258416-1jrbu8ox	8	19	groups	group	NNS
cord-258416-1jrbu8ox	8	20	of	of	IN
cord-258416-1jrbu8ox	8	21	dermatologic	dermatologic	JJ
cord-258416-1jrbu8ox	8	22	patients	patient	NNS
cord-258416-1jrbu8ox	8	23	,	,	,
cord-258416-1jrbu8ox	8	24	including	include	VBG
cord-258416-1jrbu8ox	8	25	those	those	DT
cord-258416-1jrbu8ox	8	26	whose	whose	WP$
cord-258416-1jrbu8ox	8	27	condition	condition	NN
cord-258416-1jrbu8ox	8	28	may	may	MD
cord-258416-1jrbu8ox	8	29	worsen	worsen	VB
cord-258416-1jrbu8ox	8	30	by	by	IN
cord-258416-1jrbu8ox	8	31	the	the	DT
cord-258416-1jrbu8ox	8	32	thorough	thorough	JJ
cord-258416-1jrbu8ox	8	33	disinfection	disinfection	NN
cord-258416-1jrbu8ox	8	34	measures	measure	NNS
cord-258416-1jrbu8ox	8	35	and	and	CC
cord-258416-1jrbu8ox	8	36	those	those	DT
cord-258416-1jrbu8ox	8	37	treated	treat	VBN
cord-258416-1jrbu8ox	8	38	with	with	IN
cord-258416-1jrbu8ox	8	39	immunosuppressants	immunosuppressant	NNS
cord-258416-1jrbu8ox	8	40	or	or	CC
cord-258416-1jrbu8ox	8	41	immunomodulators	immunomodulator	NNS
cord-258416-1jrbu8ox	8	42	.	.	.
cord-258416-1jrbu8ox	9	1	Following	follow	VBG
cord-258416-1jrbu8ox	9	2	patients	patient	NNS
cord-258416-1jrbu8ox	9	3	with	with	IN
cord-258416-1jrbu8ox	9	4	psoriasis	psoriasis	NN
cord-258416-1jrbu8ox	9	5	on	on	IN
cord-258416-1jrbu8ox	9	6	biological	biological	JJ
cord-258416-1jrbu8ox	9	7	therapy	therapy	NN
cord-258416-1jrbu8ox	9	8	,	,	,
cord-258416-1jrbu8ox	9	9	as	as	RB
cord-258416-1jrbu8ox	9	10	well	well	RB
cord-258416-1jrbu8ox	9	11	as	as	IN
cord-258416-1jrbu8ox	9	12	other	other	JJ
cord-258416-1jrbu8ox	9	13	inflammatory	inflammatory	JJ
cord-258416-1jrbu8ox	9	14	and	and	CC
cord-258416-1jrbu8ox	9	15	autoimmune	autoimmune	JJ
cord-258416-1jrbu8ox	9	16	cutaneous	cutaneous	JJ
cord-258416-1jrbu8ox	9	17	disorders	disorder	NNS
cord-258416-1jrbu8ox	9	18	such	such	JJ
cord-258416-1jrbu8ox	9	19	as	as	IN
cord-258416-1jrbu8ox	9	20	atopic	atopic	JJ
cord-258416-1jrbu8ox	9	21	dermatitis	dermatitis	NN
cord-258416-1jrbu8ox	9	22	,	,	,
cord-258416-1jrbu8ox	9	23	pemphigus	pemphigus	NNP
cord-258416-1jrbu8ox	9	24	,	,	,
cord-258416-1jrbu8ox	9	25	pemphigoid	pemphigoid	NNP
cord-258416-1jrbu8ox	9	26	diseases	disease	NNS
cord-258416-1jrbu8ox	9	27	,	,	,
cord-258416-1jrbu8ox	9	28	and	and	CC
cord-258416-1jrbu8ox	9	29	skin	skin	NN
cord-258416-1jrbu8ox	9	30	cancer	cancer	NN
cord-258416-1jrbu8ox	9	31	provoked	provoke	VBD
cord-258416-1jrbu8ox	9	32	the	the	DT
cord-258416-1jrbu8ox	9	33	interest	interest	NN
cord-258416-1jrbu8ox	9	34	of	of	IN
cord-258416-1jrbu8ox	9	35	dermatologists	dermatologist	NNS
cord-258416-1jrbu8ox	9	36	.	.	.
cord-258416-1jrbu8ox	10	1	Finally	finally	RB
cord-258416-1jrbu8ox	10	2	,	,	,
cord-258416-1jrbu8ox	10	3	an	an	DT
cord-258416-1jrbu8ox	10	4	intriguing	intriguing	JJ
cord-258416-1jrbu8ox	10	5	question	question	NN
cord-258416-1jrbu8ox	10	6	to	to	IN
cord-258416-1jrbu8ox	10	7	the	the	DT
cord-258416-1jrbu8ox	10	8	dermatologic	dermatologic	JJ
cord-258416-1jrbu8ox	10	9	society	society	NN
cord-258416-1jrbu8ox	10	10	was	be	VBD
cord-258416-1jrbu8ox	10	11	whether	whether	IN
cord-258416-1jrbu8ox	10	12	skin	skin	NN
cord-258416-1jrbu8ox	10	13	changes	change	NNS
cord-258416-1jrbu8ox	10	14	during	during	IN
cord-258416-1jrbu8ox	10	15	COVID‐19	covid‐19	NN
cord-258416-1jrbu8ox	10	16	infection	infection	NN
cord-258416-1jrbu8ox	10	17	exist	exist	VBP
cord-258416-1jrbu8ox	10	18	and	and	CC
cord-258416-1jrbu8ox	10	19	what	what	WP
cord-258416-1jrbu8ox	10	20	could	could	MD
cord-258416-1jrbu8ox	10	21	be	be	VB
cord-258416-1jrbu8ox	10	22	their	-PRON-	PRP$
cord-258416-1jrbu8ox	10	23	diagnostic	diagnostic	JJ
cord-258416-1jrbu8ox	10	24	or	or	CC
cord-258416-1jrbu8ox	10	25	prognostic	prognostic	JJ
cord-258416-1jrbu8ox	10	26	value	value	NN
cord-258416-1jrbu8ox	10	27	.	.	.
cord-258416-1jrbu8ox	11	1	Here	here	RB
cord-258416-1jrbu8ox	11	2	,	,	,
cord-258416-1jrbu8ox	11	3	we	-PRON-	PRP
cord-258416-1jrbu8ox	11	4	summarize	summarize	VBP
cord-258416-1jrbu8ox	11	5	skin	skin	NN
cord-258416-1jrbu8ox	11	6	conditions	condition	NNS
cord-258416-1jrbu8ox	11	7	during	during	IN
cord-258416-1jrbu8ox	11	8	the	the	DT
cord-258416-1jrbu8ox	11	9	COVID‐19	COVID‐19	NNP
cord-258416-1jrbu8ox	11	10	pandemic	pandemic	NN
cord-258416-1jrbu8ox	11	11	,	,	,
cord-258416-1jrbu8ox	11	12	patient	patient	JJ
cord-258416-1jrbu8ox	11	13	information	information	NN
cord-258416-1jrbu8ox	11	14	,	,	,
cord-258416-1jrbu8ox	11	15	and	and	CC
cord-258416-1jrbu8ox	11	16	expert	expert	NN
cord-258416-1jrbu8ox	11	17	recommendations	recommendation	NNS
cord-258416-1jrbu8ox	11	18	and	and	CC
cord-258416-1jrbu8ox	11	19	give	give	VB
cord-258416-1jrbu8ox	11	20	an	an	DT
cord-258416-1jrbu8ox	11	21	overview	overview	NN
cord-258416-1jrbu8ox	11	22	about	about	IN
cord-258416-1jrbu8ox	11	23	the	the	DT
cord-258416-1jrbu8ox	11	24	registries	registry	NNS
cord-258416-1jrbu8ox	11	25	launched	launch	VBN
cord-258416-1jrbu8ox	11	26	to	to	TO
cord-258416-1jrbu8ox	11	27	document	document	VB
cord-258416-1jrbu8ox	11	28	skin	skin	NN
cord-258416-1jrbu8ox	11	29	changes	change	NNS
cord-258416-1jrbu8ox	11	30	during	during	IN
cord-258416-1jrbu8ox	11	31	COVID‐19	COVID‐19	NNP
cord-258416-1jrbu8ox	11	32	,	,	,
cord-258416-1jrbu8ox	11	33	as	as	RB
cord-258416-1jrbu8ox	11	34	well	well	RB
cord-258416-1jrbu8ox	11	35	as	as	IN
cord-258416-1jrbu8ox	11	36	details	detail	NNS
cord-258416-1jrbu8ox	11	37	about	about	IN
cord-258416-1jrbu8ox	11	38	certain	certain	JJ
cord-258416-1jrbu8ox	11	39	patient	patient	JJ
cord-258416-1jrbu8ox	11	40	groups	group	NNS
cord-258416-1jrbu8ox	11	41	infected	infect	VBN
cord-258416-1jrbu8ox	11	42	with	with	IN
cord-258416-1jrbu8ox	11	43	SARS‐CoV‐2	SARS‐CoV‐2	NNP
cord-258416-1jrbu8ox	11	44	,	,	,
cord-258416-1jrbu8ox	11	45	for	for	IN
cord-258416-1jrbu8ox	11	46	example	example	NN
cord-258416-1jrbu8ox	11	47	,	,	,
cord-258416-1jrbu8ox	11	48	psoriasis	psoriasis	NN
cord-258416-1jrbu8ox	11	49	,	,	,
cord-258416-1jrbu8ox	11	50	atopic	atopic	JJ
cord-258416-1jrbu8ox	11	51	dermatitis	dermatitis	NN
cord-258416-1jrbu8ox	11	52	,	,	,
cord-258416-1jrbu8ox	11	53	and	and	CC
cord-258416-1jrbu8ox	11	54	autoimmune	autoimmune	JJ
cord-258416-1jrbu8ox	11	55	bullous	bullous	JJ
cord-258416-1jrbu8ox	11	56	diseases	disease	NNS
cord-258416-1jrbu8ox	11	57	.	.	.
cord-258416-1jrbu8ox	12	1	The	the	DT
cord-258416-1jrbu8ox	12	2	current	current	JJ
cord-258416-1jrbu8ox	12	3	coronavirus	coronavirus	NN
cord-258416-1jrbu8ox	12	4	disease	disease	NN
cord-258416-1jrbu8ox	12	5	(	(	-LRB-
cord-258416-1jrbu8ox	12	6	COVID-19	COVID-19	NNP
cord-258416-1jrbu8ox	12	7	)	)	-RRB-
cord-258416-1jrbu8ox	12	8	manifests	manifest	VBZ
cord-258416-1jrbu8ox	12	9	itself	-PRON-	PRP
cord-258416-1jrbu8ox	12	10	predominantly	predominantly	RB
cord-258416-1jrbu8ox	12	11	as	as	IN
cord-258416-1jrbu8ox	12	12	a	a	DT
cord-258416-1jrbu8ox	12	13	disorder	disorder	NN
cord-258416-1jrbu8ox	12	14	of	of	IN
cord-258416-1jrbu8ox	12	15	the	the	DT
cord-258416-1jrbu8ox	12	16	lower	low	JJR
cord-258416-1jrbu8ox	12	17	respiratory	respiratory	JJ
cord-258416-1jrbu8ox	12	18	tract	tract	NN
cord-258416-1jrbu8ox	12	19	leading	lead	VBG
cord-258416-1jrbu8ox	12	20	to	to	IN
cord-258416-1jrbu8ox	12	21	pneumonia	pneumonia	NN
cord-258416-1jrbu8ox	12	22	.	.	.
cord-258416-1jrbu8ox	13	1	It	-PRON-	PRP
cord-258416-1jrbu8ox	13	2	spreads	spread	VBZ
cord-258416-1jrbu8ox	13	3	through	through	IN
cord-258416-1jrbu8ox	13	4	droplets	droplet	NNS
cord-258416-1jrbu8ox	13	5	,	,	,
cord-258416-1jrbu8ox	13	6	aerosols	aerosol	NNS
cord-258416-1jrbu8ox	13	7	,	,	,
cord-258416-1jrbu8ox	13	8	and	and	CC
cord-258416-1jrbu8ox	13	9	contact	contact	NN
cord-258416-1jrbu8ox	13	10	surfaces	surface	NNS
cord-258416-1jrbu8ox	13	11	and	and	CC
cord-258416-1jrbu8ox	13	12	causes	cause	NNS
cord-258416-1jrbu8ox	13	13	fever	fever	NN
cord-258416-1jrbu8ox	13	14	,	,	,
cord-258416-1jrbu8ox	13	15	fatigue	fatigue	NN
cord-258416-1jrbu8ox	13	16	,	,	,
cord-258416-1jrbu8ox	13	17	dry	dry	JJ
cord-258416-1jrbu8ox	13	18	cough	cough	NN
cord-258416-1jrbu8ox	13	19	,	,	,
cord-258416-1jrbu8ox	13	20	and	and	CC
cord-258416-1jrbu8ox	13	21	subsequent	subsequent	JJ
cord-258416-1jrbu8ox	13	22	shortness	shortness	NN
cord-258416-1jrbu8ox	13	23	of	of	IN
cord-258416-1jrbu8ox	13	24	breath	breath	NN
cord-258416-1jrbu8ox	13	25	.	.	.
cord-258416-1jrbu8ox	14	1	1	1	CD
cord-258416-1jrbu8ox	14	2	Headache	headache	NN
cord-258416-1jrbu8ox	14	3	,	,	,
cord-258416-1jrbu8ox	14	4	myalgia	myalgia	NN
cord-258416-1jrbu8ox	14	5	,	,	,
cord-258416-1jrbu8ox	14	6	arthralgia	arthralgia	NNP
cord-258416-1jrbu8ox	14	7	,	,	,
cord-258416-1jrbu8ox	14	8	and	and	CC
cord-258416-1jrbu8ox	14	9	gastrointestinal	gastrointestinal	JJ
cord-258416-1jrbu8ox	14	10	symptoms	symptom	NNS
cord-258416-1jrbu8ox	14	11	may	may	MD
cord-258416-1jrbu8ox	14	12	occur	occur	VB
cord-258416-1jrbu8ox	14	13	in	in	IN
cord-258416-1jrbu8ox	14	14	5	5	CD
cord-258416-1jrbu8ox	14	15	-	-	SYM
cord-258416-1jrbu8ox	14	16	15	15	CD
cord-258416-1jrbu8ox	14	17	%	%	NN
cord-258416-1jrbu8ox	14	18	of	of	IN
cord-258416-1jrbu8ox	14	19	patients	patient	NNS
cord-258416-1jrbu8ox	14	20	.	.	.
cord-258416-1jrbu8ox	15	1	2	2	LS
cord-258416-1jrbu8ox	16	1	In	in	IN
cord-258416-1jrbu8ox	16	2	the	the	DT
cord-258416-1jrbu8ox	16	3	very	very	JJ
cord-258416-1jrbu8ox	16	4	beginning	beginning	NN
cord-258416-1jrbu8ox	16	5	of	of	IN
cord-258416-1jrbu8ox	16	6	the	the	DT
cord-258416-1jrbu8ox	16	7	COVID-19	covid-19	JJ
cord-258416-1jrbu8ox	16	8	outbreak	outbreak	NN
cord-258416-1jrbu8ox	16	9	,	,	,
cord-258416-1jrbu8ox	16	10	data	datum	NNS
cord-258416-1jrbu8ox	16	11	on	on	IN
cord-258416-1jrbu8ox	16	12	skin	skin	NN
cord-258416-1jrbu8ox	16	13	manifestations	manifestation	NNS
cord-258416-1jrbu8ox	16	14	were	be	VBD
cord-258416-1jrbu8ox	16	15	scarce	scarce	JJ
cord-258416-1jrbu8ox	16	16	.	.	.
cord-258416-1jrbu8ox	17	1	The	the	DT
cord-258416-1jrbu8ox	17	2	first	first	JJ
cord-258416-1jrbu8ox	17	3	look	look	NN
cord-258416-1jrbu8ox	17	4	toward	toward	IN
cord-258416-1jrbu8ox	17	5	dermatology	dermatology	NN
cord-258416-1jrbu8ox	17	6	focused	focus	VBD
cord-258416-1jrbu8ox	17	7	on	on	IN
cord-258416-1jrbu8ox	17	8	the	the	DT
cord-258416-1jrbu8ox	17	9	prevention	prevention	NN
cord-258416-1jrbu8ox	17	10	of	of	IN
cord-258416-1jrbu8ox	17	11	the	the	DT
cord-258416-1jrbu8ox	17	12	skin	skin	NN
cord-258416-1jrbu8ox	17	13	and	and	CC
cord-258416-1jrbu8ox	17	14	mucous	mucous	JJ
cord-258416-1jrbu8ox	17	15	membranes	membrane	NNS
cord-258416-1jrbu8ox	17	16	from	from	IN
cord-258416-1jrbu8ox	17	17	contact	contact	NN
cord-258416-1jrbu8ox	17	18	with	with	IN
cord-258416-1jrbu8ox	17	19	the	the	DT
cord-258416-1jrbu8ox	17	20	infection	infection	NN
cord-258416-1jrbu8ox	17	21	.	.	.
cord-258416-1jrbu8ox	18	1	Chinese	chinese	JJ
cord-258416-1jrbu8ox	18	2	dermatologists	dermatologist	NNS
cord-258416-1jrbu8ox	18	3	were	be	VBD
cord-258416-1jrbu8ox	18	4	the	the	DT
cord-258416-1jrbu8ox	18	5	first	first	JJ
cord-258416-1jrbu8ox	18	6	to	to	TO
cord-258416-1jrbu8ox	18	7	publish	publish	VB
cord-258416-1jrbu8ox	18	8	a	a	DT
cord-258416-1jrbu8ox	18	9	consensus	consensus	NN
cord-258416-1jrbu8ox	18	10	on	on	IN
cord-258416-1jrbu8ox	18	11	the	the	DT
cord-258416-1jrbu8ox	18	12	adequate	adequate	JJ
cord-258416-1jrbu8ox	18	13	measures	measure	NNS
cord-258416-1jrbu8ox	18	14	for	for	IN
cord-258416-1jrbu8ox	18	15	topical	topical	JJ
cord-258416-1jrbu8ox	18	16	disinfection	disinfection	NN
cord-258416-1jrbu8ox	18	17	in	in	IN
cord-258416-1jrbu8ox	18	18	the	the	DT
cord-258416-1jrbu8ox	18	19	new	new	JJ
cord-258416-1jrbu8ox	18	20	pandemic	pandemic	NN
cord-258416-1jrbu8ox	18	21	situation	situation	NN
cord-258416-1jrbu8ox	18	22	.	.	.
cord-258416-1jrbu8ox	19	1	3	3	LS
cord-258416-1jrbu8ox	20	1	Wearing	wear	VBG
cord-258416-1jrbu8ox	20	2	protective	protective	JJ
cord-258416-1jrbu8ox	20	3	masks	mask	NNS
cord-258416-1jrbu8ox	20	4	,	,	,
cord-258416-1jrbu8ox	20	5	goggles	goggle	NNS
cord-258416-1jrbu8ox	20	6	,	,	,
cord-258416-1jrbu8ox	20	7	and	and	CC
cord-258416-1jrbu8ox	20	8	gloves	glove	NNS
cord-258416-1jrbu8ox	20	9	,	,	,
cord-258416-1jrbu8ox	20	10	thorough	thorough	JJ
cord-258416-1jrbu8ox	20	11	hand	hand	NN
cord-258416-1jrbu8ox	20	12	washing	washing	NN
cord-258416-1jrbu8ox	20	13	,	,	,
cord-258416-1jrbu8ox	20	14	as	as	RB
cord-258416-1jrbu8ox	20	15	well	well	RB
cord-258416-1jrbu8ox	20	16	as	as	IN
cord-258416-1jrbu8ox	20	17	frequent	frequent	JJ
cord-258416-1jrbu8ox	20	18	use	use	NN
cord-258416-1jrbu8ox	20	19	of	of	IN
cord-258416-1jrbu8ox	20	20	topical	topical	JJ
cord-258416-1jrbu8ox	20	21	antiseptics	antiseptic	NNS
cord-258416-1jrbu8ox	20	22	became	become	VBD
cord-258416-1jrbu8ox	20	23	obligatory	obligatory	JJ
cord-258416-1jrbu8ox	20	24	for	for	IN
cord-258416-1jrbu8ox	20	25	a	a	DT
cord-258416-1jrbu8ox	20	26	broad	broad	JJ
cord-258416-1jrbu8ox	20	27	spectrum	spectrum	NN
cord-258416-1jrbu8ox	20	28	of	of	IN
cord-258416-1jrbu8ox	20	29	the	the	DT
cord-258416-1jrbu8ox	20	30	population	population	NN
cord-258416-1jrbu8ox	20	31	and	and	CC
cord-258416-1jrbu8ox	20	32	medical	medical	JJ
cord-258416-1jrbu8ox	20	33	staff	staff	NN
cord-258416-1jrbu8ox	20	34	.	.	.
cord-258416-1jrbu8ox	21	1	Very	very	RB
cord-258416-1jrbu8ox	21	2	soon	soon	RB
cord-258416-1jrbu8ox	21	3	this	this	DT
cord-258416-1jrbu8ox	21	4	resulted	result	VBD
cord-258416-1jrbu8ox	21	5	in	in	IN
cord-258416-1jrbu8ox	21	6	occupational	occupational	JJ
cord-258416-1jrbu8ox	21	7	skin	skin	NN
cord-258416-1jrbu8ox	21	8	damage	damage	NN
cord-258416-1jrbu8ox	21	9	among	among	IN
cord-258416-1jrbu8ox	21	10	medical	medical	JJ
cord-258416-1jrbu8ox	21	11	specialists	specialist	NNS
cord-258416-1jrbu8ox	21	12	including	include	VBG
cord-258416-1jrbu8ox	21	13	facial	facial	JJ
cord-258416-1jrbu8ox	21	14	skin	skin	NN
cord-258416-1jrbu8ox	21	15	injury	injury	NN
cord-258416-1jrbu8ox	21	16	on	on	IN
cord-258416-1jrbu8ox	21	17	the	the	DT
cord-258416-1jrbu8ox	21	18	back	back	NN
cord-258416-1jrbu8ox	21	19	of	of	IN
cord-258416-1jrbu8ox	21	20	the	the	DT
cord-258416-1jrbu8ox	21	21	nose	nose	NN
cord-258416-1jrbu8ox	21	22	,	,	,
cord-258416-1jrbu8ox	21	23	forehead	forehead	NN
cord-258416-1jrbu8ox	21	24	,	,	,
cord-258416-1jrbu8ox	21	25	and	and	CC
cord-258416-1jrbu8ox	21	26	suprazygomatic	suprazygomatic	JJ
cord-258416-1jrbu8ox	21	27	area	area	NN
cord-258416-1jrbu8ox	21	28	.	.	.
cord-258416-1jrbu8ox	22	1	4	4	LS
cord-258416-1jrbu8ox	22	2	,	,	,
cord-258416-1jrbu8ox	22	3	5	5	CD
cord-258416-1jrbu8ox	22	4	Additionally	additionally	RB
cord-258416-1jrbu8ox	22	5	,	,	,
cord-258416-1jrbu8ox	22	6	damage	damage	NN
cord-258416-1jrbu8ox	22	7	of	of	IN
cord-258416-1jrbu8ox	22	8	the	the	DT
cord-258416-1jrbu8ox	22	9	skin	skin	NN
cord-258416-1jrbu8ox	22	10	barrier	barrier	NN
cord-258416-1jrbu8ox	22	11	through	through	IN
cord-258416-1jrbu8ox	22	12	aggressive	aggressive	JJ
cord-258416-1jrbu8ox	22	13	disinfection	disinfection	NN
cord-258416-1jrbu8ox	22	14	or	or	CC
cord-258416-1jrbu8ox	22	15	wearing	wear	VBG
cord-258416-1jrbu8ox	22	16	gloves	glove	NNS
cord-258416-1jrbu8ox	22	17	could	could	MD
cord-258416-1jrbu8ox	22	18	be	be	VB
cord-258416-1jrbu8ox	22	19	considered	consider	VBN
cord-258416-1jrbu8ox	22	20	a	a	DT
cord-258416-1jrbu8ox	22	21	prerequisite	prerequisite	NN
cord-258416-1jrbu8ox	22	22	for	for	IN
cord-258416-1jrbu8ox	22	23	provoking	provoke	VBG
cord-258416-1jrbu8ox	22	24	or	or	CC
cord-258416-1jrbu8ox	22	25	exacerbating	exacerbate	VBG
cord-258416-1jrbu8ox	22	26	of	of	IN
cord-258416-1jrbu8ox	22	27	contact	contact	NN
cord-258416-1jrbu8ox	22	28	or	or	CC
cord-258416-1jrbu8ox	22	29	atopic	atopic	JJ
cord-258416-1jrbu8ox	22	30	dermatitis	dermatitis	NN
cord-258416-1jrbu8ox	22	31	,	,	,
cord-258416-1jrbu8ox	22	32	chronic	chronic	JJ
cord-258416-1jrbu8ox	22	33	hand	hand	NN
cord-258416-1jrbu8ox	22	34	eczema	eczema	NN
cord-258416-1jrbu8ox	22	35	,	,	,
cord-258416-1jrbu8ox	22	36	skin	skin	NN
cord-258416-1jrbu8ox	22	37	candidiasis	candidiasis	NN
cord-258416-1jrbu8ox	22	38	,	,	,
cord-258416-1jrbu8ox	22	39	etc	etc	FW
cord-258416-1jrbu8ox	22	40	.	.	.
cord-258416-1jrbu8ox	23	1	The	the	DT
cord-258416-1jrbu8ox	23	2	second	second	JJ
cord-258416-1jrbu8ox	23	3	wave	wave	NN
cord-258416-1jrbu8ox	23	4	of	of	IN
cord-258416-1jrbu8ox	23	5	COVID-19-related	covid-19-related	JJ
cord-258416-1jrbu8ox	23	6	dermatological	dermatological	JJ
cord-258416-1jrbu8ox	23	7	publications	publication	NNS
cord-258416-1jrbu8ox	23	8	was	be	VBD
cord-258416-1jrbu8ox	23	9	provoked	provoke	VBN
cord-258416-1jrbu8ox	23	10	by	by	IN
cord-258416-1jrbu8ox	23	11	the	the	DT
cord-258416-1jrbu8ox	23	12	concern	concern	NN
cord-258416-1jrbu8ox	23	13	to	to	IN
cord-258416-1jrbu8ox	23	14	all	all	DT
cord-258416-1jrbu8ox	23	15	patients	patient	NNS
cord-258416-1jrbu8ox	23	16	with	with	IN
cord-258416-1jrbu8ox	23	17	severe	severe	JJ
cord-258416-1jrbu8ox	23	18	dermatological	dermatological	JJ
cord-258416-1jrbu8ox	23	19	diseases	disease	NNS
cord-258416-1jrbu8ox	23	20	who	who	WP
cord-258416-1jrbu8ox	23	21	undergo	undergo	VBP
cord-258416-1jrbu8ox	23	22	treatment	treatment	NN
cord-258416-1jrbu8ox	23	23	with	with	IN
cord-258416-1jrbu8ox	23	24	biological	biological	JJ
cord-258416-1jrbu8ox	23	25	agents	agent	NNS
cord-258416-1jrbu8ox	23	26	or	or	CC
cord-258416-1jrbu8ox	23	27	other	other	JJ
cord-258416-1jrbu8ox	23	28	types	type	NNS
cord-258416-1jrbu8ox	23	29	of	of	IN
cord-258416-1jrbu8ox	23	30	immunosuppressive	immunosuppressive	JJ
cord-258416-1jrbu8ox	23	31	or	or	CC
cord-258416-1jrbu8ox	23	32	immunomodulatory	immunomodulatory	JJ
cord-258416-1jrbu8ox	23	33	therapies	therapy	NNS
cord-258416-1jrbu8ox	23	34	.	.	.
cord-258416-1jrbu8ox	24	1	6	6	CD
cord-258416-1jrbu8ox	24	2	-	-	SYM
cord-258416-1jrbu8ox	24	3	8	8	CD
cord-258416-1jrbu8ox	24	4	Psoriasis	psoriasis	NN
cord-258416-1jrbu8ox	24	5	vulgaris	vulgaris	NN
cord-258416-1jrbu8ox	24	6	treated	treat	VBN
cord-258416-1jrbu8ox	24	7	with	with	IN
cord-258416-1jrbu8ox	24	8	biologics	biologic	NNS
cord-258416-1jrbu8ox	24	9	has	have	VBZ
cord-258416-1jrbu8ox	24	10	already	already	RB
cord-258416-1jrbu8ox	24	11	been	be	VBN
cord-258416-1jrbu8ox	24	12	reported	report	VBN
cord-258416-1jrbu8ox	24	13	to	to	TO
cord-258416-1jrbu8ox	24	14	exacerbate	exacerbate	VB
cord-258416-1jrbu8ox	24	15	from	from	IN
cord-258416-1jrbu8ox	24	16	various	various	JJ
cord-258416-1jrbu8ox	24	17	infectious	infectious	JJ
cord-258416-1jrbu8ox	24	18	diseases	disease	NNS
cord-258416-1jrbu8ox	24	19	like	like	IN
cord-258416-1jrbu8ox	24	20	zika	zika	NNP
cord-258416-1jrbu8ox	24	21	and	and	CC
cord-258416-1jrbu8ox	24	22	dengue	dengue	NN
cord-258416-1jrbu8ox	24	23	virus	virus	NN
cord-258416-1jrbu8ox	24	24	.	.	.
cord-258416-1jrbu8ox	25	1	9	9	CD
cord-258416-1jrbu8ox	25	2	Psoriasis	psoriasis	NN
cord-258416-1jrbu8ox	25	3	was	be	VBD
cord-258416-1jrbu8ox	25	4	the	the	DT
cord-258416-1jrbu8ox	25	5	first	first	JJ
cord-258416-1jrbu8ox	25	6	dermatosis	dermatosis	NN
cord-258416-1jrbu8ox	25	7	during	during	IN
cord-258416-1jrbu8ox	25	8	the	the	DT
cord-258416-1jrbu8ox	25	9	COVID-19	COVID-19	NNP
cord-258416-1jrbu8ox	25	10	pandemic	pandemic	NN
cord-258416-1jrbu8ox	25	11	that	that	WDT
cord-258416-1jrbu8ox	25	12	drew	draw	VBD
cord-258416-1jrbu8ox	25	13	the	the	DT
cord-258416-1jrbu8ox	25	14	attention	attention	NN
cord-258416-1jrbu8ox	25	15	of	of	IN
cord-258416-1jrbu8ox	25	16	dermatologists	dermatologist	NNS
cord-258416-1jrbu8ox	25	17	owing	owe	VBG
cord-258416-1jrbu8ox	25	18	to	to	IN
cord-258416-1jrbu8ox	25	19	the	the	DT
cord-258416-1jrbu8ox	25	20	wide	wide	JJ
cord-258416-1jrbu8ox	25	21	scope	scope	NN
cord-258416-1jrbu8ox	25	22	of	of	IN
cord-258416-1jrbu8ox	25	23	cytotoxic	cytotoxic	JJ
cord-258416-1jrbu8ox	25	24	or	or	CC
cord-258416-1jrbu8ox	25	25	biological	biological	JJ
cord-258416-1jrbu8ox	25	26	agents	agent	NNS
cord-258416-1jrbu8ox	25	27	used	use	VBN
cord-258416-1jrbu8ox	25	28	for	for	IN
cord-258416-1jrbu8ox	25	29	its	-PRON-	PRP$
cord-258416-1jrbu8ox	25	30	treatment	treatment	NN
cord-258416-1jrbu8ox	25	31	.	.	.
cord-258416-1jrbu8ox	26	1	10	10	CD
cord-258416-1jrbu8ox	26	2	,	,	,
cord-258416-1jrbu8ox	26	3	11	11	CD
cord-258416-1jrbu8ox	26	4	Patients	patient	NNS
cord-258416-1jrbu8ox	26	5	with	with	IN
cord-258416-1jrbu8ox	26	6	hidradenitis	hidradenitis	NN
cord-258416-1jrbu8ox	26	7	suppurativa	suppurativa	NN
cord-258416-1jrbu8ox	26	8	or	or	CC
cord-258416-1jrbu8ox	26	9	other	other	JJ
cord-258416-1jrbu8ox	26	10	rare	rare	JJ
cord-258416-1jrbu8ox	26	11	diseases	disease	NNS
cord-258416-1jrbu8ox	26	12	who	who	WP
cord-258416-1jrbu8ox	26	13	probably	probably	RB
cord-258416-1jrbu8ox	26	14	face	face	VBP
cord-258416-1jrbu8ox	26	15	similar	similar	JJ
cord-258416-1jrbu8ox	26	16	problems	problem	NNS
cord-258416-1jrbu8ox	26	17	were	be	VBD
cord-258416-1jrbu8ox	26	18	provided	provide	VBN
cord-258416-1jrbu8ox	26	19	information	information	NN
cord-258416-1jrbu8ox	26	20	on	on	IN
cord-258416-1jrbu8ox	26	21	the	the	DT
cord-258416-1jrbu8ox	26	22	necessary	necessary	JJ
cord-258416-1jrbu8ox	26	23	preventive	preventive	JJ
cord-258416-1jrbu8ox	26	24	measures	measure	NNS
cord-258416-1jrbu8ox	26	25	and	and	CC
cord-258416-1jrbu8ox	26	26	optional	optional	JJ
cord-258416-1jrbu8ox	26	27	treatment	treatment	NN
cord-258416-1jrbu8ox	26	28	regimens	regimen	NNS
cord-258416-1jrbu8ox	26	29	by	by	IN
cord-258416-1jrbu8ox	26	30	the	the	DT
cord-258416-1jrbu8ox	26	31	European	European	NNP
cord-258416-1jrbu8ox	26	32	Reference	Reference	NNP
cord-258416-1jrbu8ox	26	33	Networks	Networks	NNP
cord-258416-1jrbu8ox	26	34	(	(	-LRB-
cord-258416-1jrbu8ox	26	35	ERN	ERN	NNP
cord-258416-1jrbu8ox	26	36	)	)	-RRB-
cord-258416-1jrbu8ox	26	37	.	.	.
cord-258416-1jrbu8ox	27	1	12	12	CD
cord-258416-1jrbu8ox	27	2	Atopic	Atopic	NNP
cord-258416-1jrbu8ox	27	3	dermatitis	dermatitis	NN
cord-258416-1jrbu8ox	27	4	patients	patient	NNS
cord-258416-1jrbu8ox	27	5	who	who	WP
cord-258416-1jrbu8ox	27	6	demonstrate	demonstrate	VBP
cord-258416-1jrbu8ox	27	7	elevated	elevated	JJ
cord-258416-1jrbu8ox	27	8	risk	risk	NN
cord-258416-1jrbu8ox	27	9	of	of	IN
cord-258416-1jrbu8ox	27	10	respiratory	respiratory	JJ
cord-258416-1jrbu8ox	27	11	comorbidities	comorbiditie	NNS
cord-258416-1jrbu8ox	27	12	were	be	VBD
cord-258416-1jrbu8ox	27	13	advised	advise	VBN
cord-258416-1jrbu8ox	27	14	by	by	IN
cord-258416-1jrbu8ox	27	15	the	the	DT
cord-258416-1jrbu8ox	27	16	European	European	NNP
cord-258416-1jrbu8ox	27	17	Academy	Academy	NNP
cord-258416-1jrbu8ox	27	18	of	of	IN
cord-258416-1jrbu8ox	27	19	Dermatology	Dermatology	NNP
cord-258416-1jrbu8ox	27	20	and	and	CC
cord-258416-1jrbu8ox	27	21	Venereology	Venereology	NNP
cord-258416-1jrbu8ox	27	22	(	(	-LRB-
cord-258416-1jrbu8ox	27	23	EADV	EADV	NNP
cord-258416-1jrbu8ox	27	24	)	)	-RRB-
cord-258416-1jrbu8ox	27	25	task	task	NN
cord-258416-1jrbu8ox	27	26	force	force	NN
cord-258416-1jrbu8ox	27	27	on	on	IN
cord-258416-1jrbu8ox	27	28	atopic	atopic	JJ
cord-258416-1jrbu8ox	27	29	dermatitis	dermatitis	NN
cord-258416-1jrbu8ox	27	30	not	not	RB
cord-258416-1jrbu8ox	27	31	to	to	TO
cord-258416-1jrbu8ox	27	32	modify	modify	VB
cord-258416-1jrbu8ox	27	33	by	by	IN
cord-258416-1jrbu8ox	27	34	themselves	-PRON-	PRP
cord-258416-1jrbu8ox	27	35	previously	previously	RB
cord-258416-1jrbu8ox	27	36	stable	stable	JJ
cord-258416-1jrbu8ox	27	37	immune	immune	NN
cord-258416-1jrbu8ox	27	38	-	-	HYPH
cord-258416-1jrbu8ox	27	39	modulating	modulate	VBG
cord-258416-1jrbu8ox	27	40	or	or	CC
cord-258416-1jrbu8ox	27	41	immunosuppressive	immunosuppressive	JJ
cord-258416-1jrbu8ox	27	42	therapies	therapy	NNS
cord-258416-1jrbu8ox	27	43	because	because	IN
cord-258416-1jrbu8ox	27	44	of	of	IN
cord-258416-1jrbu8ox	27	45	increased	increase	VBN
cord-258416-1jrbu8ox	27	46	risk	risk	NN
cord-258416-1jrbu8ox	27	47	of	of	IN
cord-258416-1jrbu8ox	27	48	relapses	relapse	NNS
cord-258416-1jrbu8ox	27	49	.	.	.
cord-258416-1jrbu8ox	28	1	13	13	CD
cord-258416-1jrbu8ox	28	2	Patients	patient	NNS
cord-258416-1jrbu8ox	28	3	with	with	IN
cord-258416-1jrbu8ox	28	4	autoimmune	autoimmune	JJ
cord-258416-1jrbu8ox	28	5	bullous	bullous	JJ
cord-258416-1jrbu8ox	28	6	dermatoses	dermatosis	NNS
cord-258416-1jrbu8ox	28	7	,	,	,
cord-258416-1jrbu8ox	28	8	especially	especially	RB
cord-258416-1jrbu8ox	28	9	those	those	DT
cord-258416-1jrbu8ox	28	10	suffering	suffer	VBG
cord-258416-1jrbu8ox	28	11	from	from	IN
cord-258416-1jrbu8ox	28	12	pemphigus	pemphigus	NNP
cord-258416-1jrbu8ox	28	13	and	and	CC
cord-258416-1jrbu8ox	28	14	mucous	mucous	JJ
cord-258416-1jrbu8ox	28	15	membrane	membrane	NN
cord-258416-1jrbu8ox	28	16	pemphigoid	pemphigoid	NNP
cord-258416-1jrbu8ox	28	17	,	,	,
cord-258416-1jrbu8ox	28	18	were	be	VBD
cord-258416-1jrbu8ox	28	19	informed	inform	VBN
cord-258416-1jrbu8ox	28	20	by	by	IN
cord-258416-1jrbu8ox	28	21	the	the	DT
cord-258416-1jrbu8ox	28	22	respective	respective	JJ
cord-258416-1jrbu8ox	28	23	AIBD	AIBD	NNP
cord-258416-1jrbu8ox	28	24	task	task	NN
cord-258416-1jrbu8ox	28	25	force	force	NN
cord-258416-1jrbu8ox	28	26	on	on	IN
cord-258416-1jrbu8ox	28	27	the	the	DT
cord-258416-1jrbu8ox	28	28	effects	effect	NNS
cord-258416-1jrbu8ox	28	29	of	of	IN
cord-258416-1jrbu8ox	28	30	systemic	systemic	JJ
cord-258416-1jrbu8ox	28	31	corticosteroids	corticosteroid	NNS
cord-258416-1jrbu8ox	28	32	,	,	,
cord-258416-1jrbu8ox	28	33	steroid	steroid	NN
cord-258416-1jrbu8ox	28	34	-	-	HYPH
cord-258416-1jrbu8ox	28	35	sparing	spare	VBG
cord-258416-1jrbu8ox	28	36	agents	agent	NNS
cord-258416-1jrbu8ox	28	37	,	,	,
cord-258416-1jrbu8ox	28	38	rituximab	rituximab	NN
cord-258416-1jrbu8ox	28	39	,	,	,
cord-258416-1jrbu8ox	28	40	and	and	CC
cord-258416-1jrbu8ox	28	41	other	other	JJ
cord-258416-1jrbu8ox	28	42	treatment	treatment	NN
cord-258416-1jrbu8ox	28	43	options	option	NNS
cord-258416-1jrbu8ox	28	44	during	during	IN
cord-258416-1jrbu8ox	28	45	the	the	DT
cord-258416-1jrbu8ox	28	46	COVID-19	COVID-19	NNP
cord-258416-1jrbu8ox	28	47	pandemic	pandemic	NN
cord-258416-1jrbu8ox	28	48	.	.	.
cord-258416-1jrbu8ox	29	1	[	[	-LRB-
cord-258416-1jrbu8ox	29	2	14	14	CD
cord-258416-1jrbu8ox	29	3	]	]	-RRB-
cord-258416-1jrbu8ox	29	4	[	[	-LRB-
cord-258416-1jrbu8ox	29	5	15	15	CD
cord-258416-1jrbu8ox	29	6	]	]	-RRB-
cord-258416-1jrbu8ox	29	7	[	[	-LRB-
cord-258416-1jrbu8ox	29	8	16	16	CD
cord-258416-1jrbu8ox	29	9	]	]	-RRB-
cord-258416-1jrbu8ox	30	1	Patients	patient	NNS
cord-258416-1jrbu8ox	30	2	with	with	IN
cord-258416-1jrbu8ox	30	3	connective	connective	JJ
cord-258416-1jrbu8ox	30	4	tissue	tissue	NN
cord-258416-1jrbu8ox	30	5	diseases	disease	NNS
cord-258416-1jrbu8ox	30	6	on	on	IN
cord-258416-1jrbu8ox	30	7	disease	disease	NN
cord-258416-1jrbu8ox	30	8	-	-	HYPH
cord-258416-1jrbu8ox	30	9	modifying	modify	VBG
cord-258416-1jrbu8ox	30	10	antirheumatic	antirheumatic	JJ
cord-258416-1jrbu8ox	30	11	drugs	drug	NNS
cord-258416-1jrbu8ox	30	12	,	,	,
cord-258416-1jrbu8ox	30	13	biologics	biologic	NNS
cord-258416-1jrbu8ox	30	14	,	,	,
cord-258416-1jrbu8ox	30	15	or	or	CC
cord-258416-1jrbu8ox	30	16	other	other	JJ
cord-258416-1jrbu8ox	30	17	immunosuppressive	immunosuppressive	JJ
cord-258416-1jrbu8ox	30	18	medications	medication	NNS
cord-258416-1jrbu8ox	30	19	were	be	VBD
cord-258416-1jrbu8ox	30	20	advised	advise	VBN
cord-258416-1jrbu8ox	30	21	to	to	TO
cord-258416-1jrbu8ox	30	22	consult	consult	VB
cord-258416-1jrbu8ox	30	23	their	-PRON-	PRP$
cord-258416-1jrbu8ox	30	24	rheumatologist	rheumatologist	NN
cord-258416-1jrbu8ox	30	25	and	and	CC
cord-258416-1jrbu8ox	30	26	stop	stop	VB
cord-258416-1jrbu8ox	30	27	these	these	DT
cord-258416-1jrbu8ox	30	28	drugs	drug	NNS
cord-258416-1jrbu8ox	30	29	during	during	IN
cord-258416-1jrbu8ox	30	30	an	an	DT
cord-258416-1jrbu8ox	30	31	infection	infection	NN
cord-258416-1jrbu8ox	30	32	,	,	,
cord-258416-1jrbu8ox	30	33	while	while	IN
cord-258416-1jrbu8ox	30	34	noninfected	noninfected	JJ
cord-258416-1jrbu8ox	30	35	patients	patient	NNS
cord-258416-1jrbu8ox	30	36	are	be	VBP
cord-258416-1jrbu8ox	30	37	required	require	VBN
cord-258416-1jrbu8ox	30	38	to	to	TO
cord-258416-1jrbu8ox	30	39	continue	continue	VB
cord-258416-1jrbu8ox	30	40	their	-PRON-	PRP$
cord-258416-1jrbu8ox	30	41	medication	medication	NN
cord-258416-1jrbu8ox	30	42	during	during	IN
cord-258416-1jrbu8ox	30	43	the	the	DT
cord-258416-1jrbu8ox	30	44	epidemic	epidemic	NN
cord-258416-1jrbu8ox	30	45	.	.	.
cord-258416-1jrbu8ox	31	1	17	17	CD
cord-258416-1jrbu8ox	31	2	19	19	CD
cord-258416-1jrbu8ox	31	3	,	,	,
cord-258416-1jrbu8ox	31	4	20	20	CD
cord-258416-1jrbu8ox	32	1	In	in	IN
cord-258416-1jrbu8ox	32	2	the	the	DT
cord-258416-1jrbu8ox	32	3	meanwhile	meanwhile	RB
cord-258416-1jrbu8ox	32	4	,	,	,
cord-258416-1jrbu8ox	32	5	dermatologic	dermatologic	JJ
cord-258416-1jrbu8ox	32	6	surgeons	surgeon	NNS
cord-258416-1jrbu8ox	32	7	and	and	CC
cord-258416-1jrbu8ox	32	8	dermoscopists	dermoscopist	NNS
cord-258416-1jrbu8ox	32	9	alarmed	alarm	VBD
cord-258416-1jrbu8ox	32	10	on	on	IN
cord-258416-1jrbu8ox	32	11	the	the	DT
cord-258416-1jrbu8ox	32	12	possible	possible	JJ
cord-258416-1jrbu8ox	32	13	delay	delay	NN
cord-258416-1jrbu8ox	32	14	and	and	CC
cord-258416-1jrbu8ox	32	15	risk	risk	NN
cord-258416-1jrbu8ox	32	16	of	of	IN
cord-258416-1jrbu8ox	32	17	complications	complication	NNS
cord-258416-1jrbu8ox	32	18	in	in	IN
cord-258416-1jrbu8ox	32	19	diagnosing	diagnosing	NN
cord-258416-1jrbu8ox	32	20	and	and	CC
cord-258416-1jrbu8ox	32	21	treatment	treatment	NN
cord-258416-1jrbu8ox	32	22	of	of	IN
cord-258416-1jrbu8ox	32	23	nonmelanoma	nonmelanoma	NNP
cord-258416-1jrbu8ox	32	24	skin	skin	NN
cord-258416-1jrbu8ox	32	25	cancer	cancer	NN
cord-258416-1jrbu8ox	32	26	,	,	,
cord-258416-1jrbu8ox	32	27	melanoma	melanoma	NN
cord-258416-1jrbu8ox	32	28	,	,	,
cord-258416-1jrbu8ox	32	29	and	and	CC
cord-258416-1jrbu8ox	32	30	lymphoma	lymphoma	NN
cord-258416-1jrbu8ox	32	31	.	.	.
cord-258416-1jrbu8ox	33	1	[	[	-LRB-
cord-258416-1jrbu8ox	33	2	21	21	CD
cord-258416-1jrbu8ox	33	3	]	]	-RRB-
cord-258416-1jrbu8ox	33	4	[	[	-LRB-
cord-258416-1jrbu8ox	33	5	22	22	CD
cord-258416-1jrbu8ox	33	6	]	]	-RRB-
cord-258416-1jrbu8ox	34	1	[	[	-LRB-
cord-258416-1jrbu8ox	34	2	23	23	CD
cord-258416-1jrbu8ox	34	3	]	]	-RRB-
cord-258416-1jrbu8ox	35	1	[	[	-LRB-
cord-258416-1jrbu8ox	35	2	24	24	CD
cord-258416-1jrbu8ox	35	3	]	]	-RRB-
cord-258416-1jrbu8ox	35	4	[	[	-LRB-
cord-258416-1jrbu8ox	35	5	25	25	CD
cord-258416-1jrbu8ox	35	6	]	]	-RRB-
cord-258416-1jrbu8ox	36	1	[	[	-LRB-
cord-258416-1jrbu8ox	36	2	26	26	CD
cord-258416-1jrbu8ox	36	3	]	]	-RRB-
cord-258416-1jrbu8ox	36	4	Reorganization	Reorganization	NNP
cord-258416-1jrbu8ox	36	5	of	of	IN
cord-258416-1jrbu8ox	36	6	the	the	DT
cord-258416-1jrbu8ox	36	7	work	work	NN
cord-258416-1jrbu8ox	36	8	in	in	IN
cord-258416-1jrbu8ox	36	9	dermatology	dermatology	NN
cord-258416-1jrbu8ox	36	10	units	unit	NNS
cord-258416-1jrbu8ox	36	11	was	be	VBD
cord-258416-1jrbu8ox	36	12	proposed	propose	VBN
cord-258416-1jrbu8ox	36	13	for	for	IN
cord-258416-1jrbu8ox	36	14	maximum	maximum	JJ
cord-258416-1jrbu8ox	36	15	safety	safety	NN
cord-258416-1jrbu8ox	36	16	of	of	IN
cord-258416-1jrbu8ox	36	17	both	both	DT
cord-258416-1jrbu8ox	36	18	patients	patient	NNS
cord-258416-1jrbu8ox	36	19	and	and	CC
cord-258416-1jrbu8ox	36	20	staff	staff	NN
cord-258416-1jrbu8ox	36	21	.	.	.
cord-258416-1jrbu8ox	37	1	[	[	-LRB-
cord-258416-1jrbu8ox	37	2	27	27	CD
cord-258416-1jrbu8ox	37	3	]	]	-RRB-
cord-258416-1jrbu8ox	37	4	[	[	-LRB-
cord-258416-1jrbu8ox	37	5	28	28	CD
cord-258416-1jrbu8ox	37	6	]	]	-RRB-
cord-258416-1jrbu8ox	37	7	[	[	-LRB-
cord-258416-1jrbu8ox	37	8	29	29	CD
cord-258416-1jrbu8ox	37	9	]	]	-RRB-
cord-258416-1jrbu8ox	38	1	Severe	severe	JJ
cord-258416-1jrbu8ox	38	2	acute	acute	JJ
cord-258416-1jrbu8ox	38	3	respiratory	respiratory	JJ
cord-258416-1jrbu8ox	38	4	syndrome	syndrome	NN
cord-258416-1jrbu8ox	38	5	coronavirus-2	coronavirus-2	NN
cord-258416-1jrbu8ox	39	1	(	(	-LRB-
cord-258416-1jrbu8ox	39	2	SARS	SARS	NNP
cord-258416-1jrbu8ox	39	3	-	-	HYPH
cord-258416-1jrbu8ox	39	4	CoV-2	CoV-2	NNP
cord-258416-1jrbu8ox	39	5	)	)	-RRB-
cord-258416-1jrbu8ox	39	6	took	take	VBD
cord-258416-1jrbu8ox	39	7	place	place	NN
cord-258416-1jrbu8ox	39	8	among	among	IN
cord-258416-1jrbu8ox	39	9	the	the	DT
cord-258416-1jrbu8ox	39	10	streptococcal	streptococcal	JJ
cord-258416-1jrbu8ox	39	11	infections	infection	NNS
cord-258416-1jrbu8ox	39	12	,	,	,
cord-258416-1jrbu8ox	39	13	varicella	varicella	NN
cord-258416-1jrbu8ox	39	14	,	,	,
cord-258416-1jrbu8ox	39	15	measles	measle	NNS
cord-258416-1jrbu8ox	39	16	,	,	,
cord-258416-1jrbu8ox	39	17	hepatitis	hepatitis	NNP
cord-258416-1jrbu8ox	39	18	B	B	NNP
cord-258416-1jrbu8ox	39	19	and	and	CC
cord-258416-1jrbu8ox	39	20	C	C	NNP
cord-258416-1jrbu8ox	39	21	,	,	,
cord-258416-1jrbu8ox	39	22	and	and	CC
cord-258416-1jrbu8ox	39	23	AIDS	AIDS	NNP
cord-258416-1jrbu8ox	39	24	with	with	IN
cord-258416-1jrbu8ox	39	25	which	which	WDT
cord-258416-1jrbu8ox	39	26	dermatologists	dermatologist	NNS
cord-258416-1jrbu8ox	39	27	are	be	VBP
cord-258416-1jrbu8ox	39	28	often	often	RB
cord-258416-1jrbu8ox	39	29	in	in	IN
cord-258416-1jrbu8ox	39	30	contact	contact	NN
cord-258416-1jrbu8ox	39	31	.	.	.
cord-258416-1jrbu8ox	40	1	30	30	CD
cord-258416-1jrbu8ox	40	2	Patient	Patient	NNP
cord-258416-1jrbu8ox	40	3	recommendations	recommendation	NNS
cord-258416-1jrbu8ox	40	4	and	and	CC
cord-258416-1jrbu8ox	40	5	guidelines	guideline	NNS
cord-258416-1jrbu8ox	40	6	on	on	IN
cord-258416-1jrbu8ox	40	7	specific	specific	JJ
cord-258416-1jrbu8ox	40	8	dermatological	dermatological	JJ
cord-258416-1jrbu8ox	40	9	conditions	condition	NNS
cord-258416-1jrbu8ox	40	10	during	during	IN
cord-258416-1jrbu8ox	40	11	the	the	DT
cord-258416-1jrbu8ox	40	12	COVID-19	covid-19	JJ
cord-258416-1jrbu8ox	40	13	pandemic	pandemic	NN
cord-258416-1jrbu8ox	40	14	are	be	VBP
cord-258416-1jrbu8ox	40	15	detailed	detail	VBN
cord-258416-1jrbu8ox	40	16	in	in	IN
cord-258416-1jrbu8ox	40	17	Table	Table	NNP
cord-258416-1jrbu8ox	40	18	1	1	CD
cord-258416-1jrbu8ox	40	19	.	.	.
cord-258416-1jrbu8ox	41	1	The	the	DT
cord-258416-1jrbu8ox	41	2	most	most	RBS
cord-258416-1jrbu8ox	41	3	intriguing	intriguing	JJ
cord-258416-1jrbu8ox	41	4	question	question	NN
cord-258416-1jrbu8ox	41	5	to	to	IN
cord-258416-1jrbu8ox	41	6	all	all	DT
cord-258416-1jrbu8ox	41	7	dermatologists	dermatologist	NNS
cord-258416-1jrbu8ox	41	8	was	be	VBD
cord-258416-1jrbu8ox	41	9	whether	whether	IN
cord-258416-1jrbu8ox	41	10	with	with	IN
cord-258416-1jrbu8ox	41	11	the	the	DT
cord-258416-1jrbu8ox	41	12	disease	disease	NN
cord-258416-1jrbu8ox	41	13	severity	severity	NN
cord-258416-1jrbu8ox	41	14	was	be	VBD
cord-258416-1jrbu8ox	41	15	found	find	VBN
cord-258416-1jrbu8ox	41	16	,	,	,
cord-258416-1jrbu8ox	41	17	a	a	DT
cord-258416-1jrbu8ox	41	18	nonspecific	nonspecific	JJ
cord-258416-1jrbu8ox	41	19	character	character	NN
cord-258416-1jrbu8ox	41	20	was	be	VBD
cord-258416-1jrbu8ox	41	21	presumed	presume	VBN
cord-258416-1jrbu8ox	41	22	.	.	.
cord-258416-1jrbu8ox	42	1	33	33	CD
cord-258416-1jrbu8ox	43	1	In	in	IN
cord-258416-1jrbu8ox	43	2	a	a	DT
cord-258416-1jrbu8ox	43	3	French	french	JJ
cord-258416-1jrbu8ox	43	4	prospective	prospective	JJ
cord-258416-1jrbu8ox	43	5	study	study	NN
cord-258416-1jrbu8ox	43	6	on	on	IN
cord-258416-1jrbu8ox	43	7	the	the	DT
cord-258416-1jrbu8ox	43	8	incidence	incidence	NN
cord-258416-1jrbu8ox	43	9	and	and	CC
cord-258416-1jrbu8ox	43	10	types	type	NNS
cord-258416-1jrbu8ox	43	11	of	of	IN
cord-258416-1jrbu8ox	43	12	COVID-19-associated	covid-19-associated	JJ
cord-258416-1jrbu8ox	43	13	cutaneous	cutaneous	JJ
cord-258416-1jrbu8ox	43	14	manifestations	manifestation	NNS
cord-258416-1jrbu8ox	43	15	,	,	,
cord-258416-1jrbu8ox	43	16	skin	skin	NN
cord-258416-1jrbu8ox	43	17	involvement	involvement	NN
cord-258416-1jrbu8ox	43	18	was	be	VBD
cord-258416-1jrbu8ox	43	19	reported	report	VBN
cord-258416-1jrbu8ox	43	20	in	in	IN
cord-258416-1jrbu8ox	43	21	only	only	RB
cord-258416-1jrbu8ox	43	22	4.9	4.9	CD
cord-258416-1jrbu8ox	43	23	%	%	NN
cord-258416-1jrbu8ox	43	24	(	(	-LRB-
cord-258416-1jrbu8ox	43	25	five	five	CD
cord-258416-1jrbu8ox	43	26	patients	patient	NNS
cord-258416-1jrbu8ox	43	27	of	of	IN
cord-258416-1jrbu8ox	43	28	103	103	CD
cord-258416-1jrbu8ox	43	29	)	)	-RRB-
cord-258416-1jrbu8ox	43	30	and	and	CC
cord-258416-1jrbu8ox	43	31	presented	present	VBD
cord-258416-1jrbu8ox	43	32	as	as	IN
cord-258416-1jrbu8ox	43	33	erythematous	erythematous	JJ
cord-258416-1jrbu8ox	43	34	rash	rash	NN
cord-258416-1jrbu8ox	43	35	(	(	-LRB-
cord-258416-1jrbu8ox	43	36	two	two	CD
cord-258416-1jrbu8ox	43	37	patients	patient	NNS
cord-258416-1jrbu8ox	43	38	)	)	-RRB-
cord-258416-1jrbu8ox	43	39	and	and	CC
cord-258416-1jrbu8ox	43	40	urticaria	urticaria	NN
cord-258416-1jrbu8ox	43	41	(	(	-LRB-
cord-258416-1jrbu8ox	43	42	two	two	CD
cord-258416-1jrbu8ox	43	43	patients	patient	NNS
cord-258416-1jrbu8ox	43	44	)	)	-RRB-
cord-258416-1jrbu8ox	43	45	.	.	.
cord-258416-1jrbu8ox	44	1	Lesions	lesion	NNS
cord-258416-1jrbu8ox	44	2	appeared	appear	VBD
cord-258416-1jrbu8ox	44	3	during	during	IN
cord-258416-1jrbu8ox	44	4	the	the	DT
cord-258416-1jrbu8ox	44	5	illness	illness	NN
cord-258416-1jrbu8ox	44	6	or	or	CC
cord-258416-1jrbu8ox	44	7	the	the	DT
cord-258416-1jrbu8ox	44	8	prodromal	prodromal	JJ
cord-258416-1jrbu8ox	44	9	phase	phase	NN
cord-258416-1jrbu8ox	44	10	,	,	,
cord-258416-1jrbu8ox	44	11	affected	affect	VBN
cord-258416-1jrbu8ox	44	12	mainly	mainly	RB
cord-258416-1jrbu8ox	44	13	the	the	DT
cord-258416-1jrbu8ox	44	14	face	face	NN
cord-258416-1jrbu8ox	44	15	and	and	CC
cord-258416-1jrbu8ox	44	16	upper	upper	JJ
cord-258416-1jrbu8ox	44	17	part	part	NN
cord-258416-1jrbu8ox	44	18	of	of	IN
cord-258416-1jrbu8ox	44	19	the	the	DT
cord-258416-1jrbu8ox	44	20	body	body	NN
cord-258416-1jrbu8ox	44	21	,	,	,
cord-258416-1jrbu8ox	44	22	were	be	VBD
cord-258416-1jrbu8ox	44	23	pruritic	pruritic	JJ
cord-258416-1jrbu8ox	44	24	,	,	,
cord-258416-1jrbu8ox	44	25	and	and	CC
cord-258416-1jrbu8ox	44	26	resolved	resolve	VBD
cord-258416-1jrbu8ox	44	27	between	between	IN
cord-258416-1jrbu8ox	44	28	24	24	CD
cord-258416-1jrbu8ox	44	29	hours	hour	NNS
cord-258416-1jrbu8ox	44	30	and	and	CC
cord-258416-1jrbu8ox	44	31	6	6	CD
cord-258416-1jrbu8ox	44	32	days	day	NNS
cord-258416-1jrbu8ox	44	33	.	.	.
cord-258416-1jrbu8ox	45	1	The	the	DT
cord-258416-1jrbu8ox	45	2	authors	author	NNS
cord-258416-1jrbu8ox	45	3	concluded	conclude	VBD
cord-258416-1jrbu8ox	45	4	that	that	IN
cord-258416-1jrbu8ox	45	5	cutaneous	cutaneous	JJ
cord-258416-1jrbu8ox	45	6	manifestations	manifestation	NNS
cord-258416-1jrbu8ox	45	7	of	of	IN
cord-258416-1jrbu8ox	45	8	COVID-19	COVID-19	NNP
cord-258416-1jrbu8ox	45	9	were	be	VBD
cord-258416-1jrbu8ox	45	10	unusual	unusual	JJ
cord-258416-1jrbu8ox	45	11	and	and	CC
cord-258416-1jrbu8ox	45	12	mostly	mostly	RB
cord-258416-1jrbu8ox	45	13	nonspecific	nonspecific	JJ
cord-258416-1jrbu8ox	45	14	.	.	.
cord-258416-1jrbu8ox	46	1	34	34	CD
cord-258416-1jrbu8ox	47	1	These	these	DT
cord-258416-1jrbu8ox	47	2	initial	initial	JJ
cord-258416-1jrbu8ox	47	3	data	datum	NNS
cord-258416-1jrbu8ox	47	4	were	be	VBD
cord-258416-1jrbu8ox	47	5	followed	follow	VBN
cord-258416-1jrbu8ox	47	6	by	by	IN
cord-258416-1jrbu8ox	47	7	a	a	DT
cord-258416-1jrbu8ox	47	8	growing	grow	VBG
cord-258416-1jrbu8ox	47	9	number	number	NN
cord-258416-1jrbu8ox	47	10	of	of	IN
cord-258416-1jrbu8ox	47	11	individual	individual	JJ
cord-258416-1jrbu8ox	47	12	reports	report	NNS
cord-258416-1jrbu8ox	47	13	and	and	CC
cord-258416-1jrbu8ox	47	14	case	case	NN
cord-258416-1jrbu8ox	47	15	series	series	NN
cord-258416-1jrbu8ox	47	16	.	.	.
cord-258416-1jrbu8ox	48	1	Morbilliform	Morbilliform	NNP
cord-258416-1jrbu8ox	48	2	rash	rash	NN
cord-258416-1jrbu8ox	48	3	as	as	IN
cord-258416-1jrbu8ox	48	4	a	a	DT
cord-258416-1jrbu8ox	48	5	presenting	present	VBG
cord-258416-1jrbu8ox	48	6	symptom	symptom	NN
cord-258416-1jrbu8ox	48	7	of	of	IN
cord-258416-1jrbu8ox	48	8	COVID-19	COVID-19	NNP
cord-258416-1jrbu8ox	48	9	was	be	VBD
cord-258416-1jrbu8ox	48	10	reported	report	VBN
cord-258416-1jrbu8ox	48	11	in	in	IN
cord-258416-1jrbu8ox	48	12	a	a	DT
cord-258416-1jrbu8ox	48	13	20-year	20-year	JJ
cord-258416-1jrbu8ox	48	14	-	-	HYPH
cord-258416-1jrbu8ox	48	15	old	old	JJ
cord-258416-1jrbu8ox	48	16	previously	previously	RB
cord-258416-1jrbu8ox	48	17	healthy	healthy	JJ
cord-258416-1jrbu8ox	48	18	man	man	NN
cord-258416-1jrbu8ox	48	19	from	from	IN
cord-258416-1jrbu8ox	48	20	the	the	DT
cord-258416-1jrbu8ox	48	21	USA	USA	NNP
cord-258416-1jrbu8ox	48	22	.	.	.
cord-258416-1jrbu8ox	49	1	Future	future	JJ
cord-258416-1jrbu8ox	49	2	case	case	NN
cord-258416-1jrbu8ox	49	3	-	-	HYPH
cord-258416-1jrbu8ox	49	4	controlled	control	VBN
cord-258416-1jrbu8ox	49	5	studies	study	NNS
cord-258416-1jrbu8ox	49	6	may	may	MD
cord-258416-1jrbu8ox	49	7	potentially	potentially	RB
cord-258416-1jrbu8ox	49	8	confirm	confirm	VB
cord-258416-1jrbu8ox	49	9	AGA	AGA	NNP
cord-258416-1jrbu8ox	49	10	as	as	IN
cord-258416-1jrbu8ox	49	11	a	a	DT
cord-258416-1jrbu8ox	49	12	predictive	predictive	JJ
cord-258416-1jrbu8ox	49	13	factor	factor	NN
cord-258416-1jrbu8ox	49	14	for	for	IN
cord-258416-1jrbu8ox	49	15	increased	increase	VBN
cord-258416-1jrbu8ox	49	16	COVID-19	covid-19	JJ
cord-258416-1jrbu8ox	49	17	severity	severity	NN
cord-258416-1jrbu8ox	49	18	and	and	CC
cord-258416-1jrbu8ox	49	19	contribute	contribute	VB
cord-258416-1jrbu8ox	49	20	to	to	IN
cord-258416-1jrbu8ox	49	21	the	the	DT
cord-258416-1jrbu8ox	49	22	development	development	NN
cord-258416-1jrbu8ox	49	23	of	of	IN
cord-258416-1jrbu8ox	49	24	antiandrogen	antiandrogen	NNP
cord-258416-1jrbu8ox	49	25	therapy	therapy	NN
cord-258416-1jrbu8ox	49	26	for	for	IN
cord-258416-1jrbu8ox	49	27	SARS-	SARS-	NNP
cord-258416-1jrbu8ox	49	28	Neonatal	neonatal	JJ
cord-258416-1jrbu8ox	49	29	rashes	rash	NNS
cord-258416-1jrbu8ox	49	30	Skin	skin	VBP
cord-258416-1jrbu8ox	49	31	rashes	rash	NNS
cord-258416-1jrbu8ox	49	32	in	in	IN
cord-258416-1jrbu8ox	49	33	newborns	newborn	NNS
cord-258416-1jrbu8ox	49	34	of	of	IN
cord-258416-1jrbu8ox	49	35	COVID-19-infected	COVID-19-infected	NNP
cord-258416-1jrbu8ox	49	36	mothers	mother	NNS
cord-258416-1jrbu8ox	49	37	were	be	VBD
cord-258416-1jrbu8ox	49	38	reported	report	VBN
cord-258416-1jrbu8ox	49	39	in	in	IN
cord-258416-1jrbu8ox	49	40	two	two	CD
cord-258416-1jrbu8ox	49	41	boys	boy	NNS
cord-258416-1jrbu8ox	49	42	out	out	IN
cord-258416-1jrbu8ox	49	43	of	of	IN
cord-258416-1jrbu8ox	49	44	four	four	CD
cord-258416-1jrbu8ox	49	45	infants	infant	NNS
cord-258416-1jrbu8ox	49	46	from	from	IN
cord-258416-1jrbu8ox	49	47	China	China	NNP
cord-258416-1jrbu8ox	49	48	.	.	.
cord-258416-1jrbu8ox	50	1	Maculopapular	maculopapular	JJ
cord-258416-1jrbu8ox	50	2	rash	rash	NN
cord-258416-1jrbu8ox	50	3	scattered	scatter	VBN
cord-258416-1jrbu8ox	50	4	throughout	throughout	IN
cord-258416-1jrbu8ox	50	5	the	the	DT
cord-258416-1jrbu8ox	50	6	body	body	NN
cord-258416-1jrbu8ox	50	7	was	be	VBD
cord-258416-1jrbu8ox	50	8	observed	observe	VBN
cord-258416-1jrbu8ox	50	9	in	in	IN
cord-258416-1jrbu8ox	50	10	one	one	CD
cord-258416-1jrbu8ox	50	11	of	of	IN
cord-258416-1jrbu8ox	50	12	the	the	DT
cord-258416-1jrbu8ox	50	13	boys	boy	NNS
cord-258416-1jrbu8ox	50	14	who	who	WP
cord-258416-1jrbu8ox	50	15	was	be	VBD
cord-258416-1jrbu8ox	50	16	not	not	RB
cord-258416-1jrbu8ox	50	17	tested	test	VBN
cord-258416-1jrbu8ox	50	18	for	for	IN
cord-258416-1jrbu8ox	50	19	SARS	SARS	NNP
cord-258416-1jrbu8ox	50	20	-	-	HYPH
cord-258416-1jrbu8ox	50	21	CoV-2	CoV-2	NNP
cord-258416-1jrbu8ox	50	22	.	.	.
cord-258416-1jrbu8ox	51	1	The	the	DT
cord-258416-1jrbu8ox	51	2	rash	rash	NN
cord-258416-1jrbu8ox	51	3	resolved	resolve	VBD
cord-258416-1jrbu8ox	51	4	rapidly	rapidly	RB
cord-258416-1jrbu8ox	51	5	without	without	IN
cord-258416-1jrbu8ox	51	6	treatment	treatment	NN
cord-258416-1jrbu8ox	51	7	and	and	CC
cord-258416-1jrbu8ox	51	8	was	be	VBD
cord-258416-1jrbu8ox	51	9	followed	follow	VBN
cord-258416-1jrbu8ox	51	10	by	by	IN
cord-258416-1jrbu8ox	51	11	desquamation	desquamation	NN
cord-258416-1jrbu8ox	51	12	.	.	.
cord-258416-1jrbu8ox	52	1	Ulcerated	ulcerated	JJ
cord-258416-1jrbu8ox	52	2	facial	facial	JJ
cord-258416-1jrbu8ox	52	3	skin	skin	NN
cord-258416-1jrbu8ox	52	4	on	on	IN
cord-258416-1jrbu8ox	52	5	the	the	DT
cord-258416-1jrbu8ox	52	6	forehead	forehead	NN
cord-258416-1jrbu8ox	52	7	was	be	VBD
cord-258416-1jrbu8ox	52	8	detected	detect	VBN
cord-258416-1jrbu8ox	52	9	in	in	IN
cord-258416-1jrbu8ox	52	10	the	the	DT
cord-258416-1jrbu8ox	52	11	other	other	JJ
cord-258416-1jrbu8ox	52	12	boy	boy	NN
cord-258416-1jrbu8ox	52	13	who	who	WP
cord-258416-1jrbu8ox	52	14	was	be	VBD
cord-258416-1jrbu8ox	52	15	proven	prove	VBN
cord-258416-1jrbu8ox	52	16	to	to	TO
cord-258416-1jrbu8ox	52	17	be	be	VB
cord-258416-1jrbu8ox	52	18	SARS	SARS	NNP
cord-258416-1jrbu8ox	52	19	-	-	HYPH
cord-258416-1jrbu8ox	52	20	CoV-2	CoV-2	NNP
cord-258416-1jrbu8ox	52	21	negative	negative	JJ
cord-258416-1jrbu8ox	52	22	.	.	.
cord-258416-1jrbu8ox	53	1	Lesions	lesion	NNS
cord-258416-1jrbu8ox	53	2	were	be	VBD
cord-258416-1jrbu8ox	53	3	quickly	quickly	RB
cord-258416-1jrbu8ox	53	4	followed	follow	VBN
cord-258416-1jrbu8ox	53	5	by	by	IN
cord-258416-1jrbu8ox	53	6	diffuse	diffuse	JJ
cord-258416-1jrbu8ox	53	7	red	red	JJ
cord-258416-1jrbu8ox	53	8	papules	papule	NNS
cord-258416-1jrbu8ox	53	9	that	that	WDT
cord-258416-1jrbu8ox	53	10	spontaneously	spontaneously	RB
cord-258416-1jrbu8ox	53	11	healed	heal	VBD
cord-258416-1jrbu8ox	53	12	within	within	IN
cord-258416-1jrbu8ox	53	13	10	10	CD
cord-258416-1jrbu8ox	53	14	days	day	NNS
cord-258416-1jrbu8ox	53	15	.	.	.
cord-258416-1jrbu8ox	54	1	None	none	NN
cord-258416-1jrbu8ox	54	2	of	of	IN
cord-258416-1jrbu8ox	54	3	the	the	DT
cord-258416-1jrbu8ox	54	4	four	four	CD
cord-258416-1jrbu8ox	54	5	newborns	newborn	NNS
cord-258416-1jrbu8ox	54	6	of	of	IN
cord-258416-1jrbu8ox	54	7	COVID-19-infected	COVID-19-infected	NNP
cord-258416-1jrbu8ox	54	8	mothers	mother	NNS
cord-258416-1jrbu8ox	54	9	developed	develop	VBD
cord-258416-1jrbu8ox	54	10	disease	disease	NN
cord-258416-1jrbu8ox	54	11	,	,	,
cord-258416-1jrbu8ox	54	12	and	and	CC
cord-258416-1jrbu8ox	54	13	no	no	DT
cord-258416-1jrbu8ox	54	14	vertical	vertical	JJ
cord-258416-1jrbu8ox	54	15	transmission	transmission	NN
cord-258416-1jrbu8ox	54	16	was	be	VBD
cord-258416-1jrbu8ox	54	17	detected	detect	VBN
cord-258416-1jrbu8ox	54	18	.	.	.
cord-258416-1jrbu8ox	55	1	63	63	CD
cord-258416-1jrbu8ox	55	2	Kawasaki	Kawasaki	NNP
cord-258416-1jrbu8ox	55	3	disease	disease	NN
cord-258416-1jrbu8ox	55	4	,	,	,
cord-258416-1jrbu8ox	55	5	an	an	DT
cord-258416-1jrbu8ox	55	6	acute	acute	JJ
cord-258416-1jrbu8ox	55	7	vasculitis	vasculitis	NN
cord-258416-1jrbu8ox	55	8	of	of	IN
cord-258416-1jrbu8ox	55	9	unknown	unknown	JJ
cord-258416-1jrbu8ox	55	10	origin	origin	NN
cord-258416-1jrbu8ox	55	11	,	,	,
cord-258416-1jrbu8ox	55	12	is	be	VBZ
cord-258416-1jrbu8ox	55	13	another	another	DT
cord-258416-1jrbu8ox	55	14	possible	possible	JJ
cord-258416-1jrbu8ox	55	15	but	but	CC
cord-258416-1jrbu8ox	55	16	unproven	unproven	JJ
cord-258416-1jrbu8ox	55	17	manifestation	manifestation	NN
cord-258416-1jrbu8ox	55	18	during	during	IN
cord-258416-1jrbu8ox	55	19	COVID-19	COVID-19	NNP
cord-258416-1jrbu8ox	55	20	.	.	.
cord-258416-1jrbu8ox	56	1	It	-PRON-	PRP
cord-258416-1jrbu8ox	56	2	was	be	VBD
cord-258416-1jrbu8ox	56	3	reported	report	VBN
cord-258416-1jrbu8ox	56	4	in	in	IN
cord-258416-1jrbu8ox	56	5	a	a	DT
cord-258416-1jrbu8ox	56	6	6-month	6-month	CD
cord-258416-1jrbu8ox	56	7	-	-	HYPH
cord-258416-1jrbu8ox	56	8	old	old	JJ
cord-258416-1jrbu8ox	56	9	,	,	,
cord-258416-1jrbu8ox	56	10	 	 	_SP
cord-258416-1jrbu8ox	56	11	In	in	IN
cord-258416-1jrbu8ox	56	12	an	an	DT
cord-258416-1jrbu8ox	56	13	online	online	NN
cord-258416-1jrbu8ox	56	14	registry	registry	NN
cord-258416-1jrbu8ox	56	15	launched	launch	VBN
cord-258416-1jrbu8ox	56	16	by	by	IN
cord-258416-1jrbu8ox	56	17	the	the	DT
cord-258416-1jrbu8ox	56	18	American	American	NNP
cord-258416-1jrbu8ox	56	19	Academy	Academy	NNP
cord-258416-1jrbu8ox	56	20	of	of	IN
cord-258416-1jrbu8ox	56	21	Dermatology	Dermatology	NNP
cord-258416-1jrbu8ox	56	22	(	(	-LRB-
cord-258416-1jrbu8ox	56	23	AAD	AAD	NNP
cord-258416-1jrbu8ox	56	24	)	)	-RRB-
cord-258416-1jrbu8ox	56	25	in	in	IN
cord-258416-1jrbu8ox	56	26	collaboration	collaboration	NN
cord-258416-1jrbu8ox	56	27	with	with	IN
cord-258416-1jrbu8ox	56	28	the	the	DT
cord-258416-1jrbu8ox	56	29	International	International	NNP
cord-258416-1jrbu8ox	56	30	League	League	NNP
cord-258416-1jrbu8ox	56	31	of	of	IN
cord-258416-1jrbu8ox	56	32	Dermatological	Dermatological	NNP
cord-258416-1jrbu8ox	56	33	Societies	Societies	NNPS
cord-258416-1jrbu8ox	56	34	(	(	-LRB-
cord-258416-1jrbu8ox	56	35	ILDS	ILDS	NNP
cord-258416-1jrbu8ox	56	36	)	)	-RRB-
cord-258416-1jrbu8ox	56	37	,	,	,
cord-258416-1jrbu8ox	56	38	all	all	DT
cord-258416-1jrbu8ox	56	39	patients	patient	NNS
cord-258416-1jrbu8ox	56	40	with	with	IN
cord-258416-1jrbu8ox	56	41	skin	skin	NN
cord-258416-1jrbu8ox	56	42	lesions	lesion	NNS
cord-258416-1jrbu8ox	56	43	during	during	IN
cord-258416-1jrbu8ox	56	44	or	or	CC
cord-258416-1jrbu8ox	56	45	following	follow	VBG
cord-258416-1jrbu8ox	56	46	COVID-19	COVID-19	NNP
cord-258416-1jrbu8ox	56	47	can	can	MD
cord-258416-1jrbu8ox	56	48	be	be	VB
cord-258416-1jrbu8ox	56	49	reported	report	VBN
cord-258416-1jrbu8ox	56	50	(	(	-LRB-
cord-258416-1jrbu8ox	56	51	Table	table	NN
cord-258416-1jrbu8ox	56	52	2	2	CD
cord-258416-1jrbu8ox	56	53	)	)	-RRB-
cord-258416-1jrbu8ox	56	54	.	.	.
cord-258416-1jrbu8ox	57	1	67	67	CD
cord-258416-1jrbu8ox	58	1	The	the	DT
cord-258416-1jrbu8ox	58	2	primary	primary	JJ
cord-258416-1jrbu8ox	58	3	purpose	purpose	NN
cord-258416-1jrbu8ox	58	4	is	be	VBZ
cord-258416-1jrbu8ox	58	5	to	to	TO
cord-258416-1jrbu8ox	58	6	rapidly	rapidly	RB
cord-258416-1jrbu8ox	58	7	collect	collect	VB
cord-258416-1jrbu8ox	58	8	dermatologic	dermatologic	JJ
cord-258416-1jrbu8ox	58	9	manifestations	manifestation	NNS
cord-258416-1jrbu8ox	58	10	Furthermore	furthermore	RB
cord-258416-1jrbu8ox	58	11	,	,	,
cord-258416-1jrbu8ox	58	12	disease	disease	NN
cord-258416-1jrbu8ox	58	13	-	-	HYPH
cord-258416-1jrbu8ox	58	14	specific	specific	JJ
cord-258416-1jrbu8ox	58	15	registries	registry	NNS
cord-258416-1jrbu8ox	58	16	have	have	VBP
cord-258416-1jrbu8ox	58	17	been	be	VBN
cord-258416-1jrbu8ox	58	18	initiated	initiate	VBN
cord-258416-1jrbu8ox	58	19	,	,	,
cord-258416-1jrbu8ox	58	20	for	for	IN
cord-258416-1jrbu8ox	58	21	example	example	NN
cord-258416-1jrbu8ox	58	22	,	,	,
cord-258416-1jrbu8ox	58	23	for	for	IN
cord-258416-1jrbu8ox	58	24	patients	patient	NNS
cord-258416-1jrbu8ox	58	25	with	with	IN
cord-258416-1jrbu8ox	58	26	psoriasis	psoriasis	NN
cord-258416-1jrbu8ox	58	27	(	(	-LRB-
cord-258416-1jrbu8ox	58	28	by	by	IN
cord-258416-1jrbu8ox	58	29	PsoProtect	PsoProtect	NNP
cord-258416-1jrbu8ox	58	30	)	)	-RRB-
cord-258416-1jrbu8ox	58	31	,	,	,
cord-258416-1jrbu8ox	58	32	atopic	atopic	JJ
cord-258416-1jrbu8ox	58	33	dermatitis	dermatitis	NN
cord-258416-1jrbu8ox	58	34	(	(	-LRB-
cord-258416-1jrbu8ox	58	35	by	by	IN
cord-258416-1jrbu8ox	58	36	Secure	secure	JJ
cord-258416-1jrbu8ox	58	37	-	-	HYPH
cord-258416-1jrbu8ox	58	38	AD	ad	NN
cord-258416-1jrbu8ox	58	39	-	-	HYPH
cord-258416-1jrbu8ox	58	40	registry	registry	NN
cord-258416-1jrbu8ox	58	41	)	)	-RRB-
cord-258416-1jrbu8ox	58	42	,	,	,
cord-258416-1jrbu8ox	58	43	connective	connective	JJ
cord-258416-1jrbu8ox	58	44	tissues	tissue	NNS
cord-258416-1jrbu8ox	58	45	diseases	disease	NNS
cord-258416-1jrbu8ox	58	46	(	(	-LRB-
cord-258416-1jrbu8ox	58	47	by	by	IN
cord-258416-1jrbu8ox	58	48	EULAR	EULAR	NNP
cord-258416-1jrbu8ox	58	49	)	)	-RRB-
cord-258416-1jrbu8ox	58	50	,	,	,
cord-258416-1jrbu8ox	58	51	and	and	CC
cord-258416-1jrbu8ox	58	52	autoimmune	autoimmune	JJ
cord-258416-1jrbu8ox	58	53	blistering	blistering	JJ
cord-258416-1jrbu8ox	58	54	diseases	disease	NNS
cord-258416-1jrbu8ox	58	55	(	(	-LRB-
cord-258416-1jrbu8ox	58	56	by	by	IN
cord-258416-1jrbu8ox	58	57	the	the	DT
cord-258416-1jrbu8ox	58	58	corresponding	correspond	VBG
cord-258416-1jrbu8ox	58	59	EADV	EADV	NNP
cord-258416-1jrbu8ox	58	60	task	task	NN
cord-258416-1jrbu8ox	58	61	force	force	NN
cord-258416-1jrbu8ox	58	62	)	)	-RRB-
cord-258416-1jrbu8ox	59	1	(	(	-LRB-
cord-258416-1jrbu8ox	59	2	Table	table	NN
cord-258416-1jrbu8ox	59	3	2	2	CD
cord-258416-1jrbu8ox	59	4	)	)	-RRB-
cord-258416-1jrbu8ox	59	5	.	.	.
cord-258416-1jrbu8ox	60	1	Clinical	clinical	JJ
cord-258416-1jrbu8ox	60	2	features	feature	NNS
cord-258416-1jrbu8ox	60	3	of	of	IN
cord-258416-1jrbu8ox	60	4	2019	2019	CD
cord-258416-1jrbu8ox	60	5	novel	novel	JJ
cord-258416-1jrbu8ox	60	6	coronavirus	coronavirus	NN
cord-258416-1jrbu8ox	60	7	pneumonia	pneumonia	NN
cord-258416-1jrbu8ox	60	8	in	in	IN
cord-258416-1jrbu8ox	60	9	the	the	DT
cord-258416-1jrbu8ox	60	10	early	early	JJ
cord-258416-1jrbu8ox	60	11	stage	stage	NN
cord-258416-1jrbu8ox	60	12	from	from	IN
cord-258416-1jrbu8ox	60	13	a	a	DT
cord-258416-1jrbu8ox	60	14	fever	fever	NN
cord-258416-1jrbu8ox	60	15	clinic	clinic	NN
cord-258416-1jrbu8ox	60	16	in	in	IN
cord-258416-1jrbu8ox	60	17	Beijing	Beijing	NNP
cord-258416-1jrbu8ox	60	18	Clinical	clinical	JJ
cord-258416-1jrbu8ox	60	19	characteristics	characteristic	NNS
cord-258416-1jrbu8ox	60	20	of	of	IN
cord-258416-1jrbu8ox	60	21	Coronavirus	Coronavirus	NNP
cord-258416-1jrbu8ox	60	22	Disease	Disease	NNP
cord-258416-1jrbu8ox	60	23	2019	2019	CD
cord-258416-1jrbu8ox	60	24	in	in	IN
cord-258416-1jrbu8ox	60	25	China	China	NNP
cord-258416-1jrbu8ox	60	26	Consensus	Consensus	NNP
cord-258416-1jrbu8ox	60	27	of	of	IN
cord-258416-1jrbu8ox	60	28	Chinese	chinese	JJ
cord-258416-1jrbu8ox	60	29	experts	expert	NNS
cord-258416-1jrbu8ox	60	30	on	on	IN
cord-258416-1jrbu8ox	60	31	protection	protection	NN
cord-258416-1jrbu8ox	60	32	of	of	IN
cord-258416-1jrbu8ox	60	33	skin	skin	NN
cord-258416-1jrbu8ox	60	34	and	and	CC
cord-258416-1jrbu8ox	60	35	mucous	mucous	JJ
cord-258416-1jrbu8ox	60	36	membrane	membrane	NN
cord-258416-1jrbu8ox	60	37	barrier	barrier	NN
cord-258416-1jrbu8ox	60	38	for	for	IN
cord-258416-1jrbu8ox	60	39	healthcare	healthcare	NN
cord-258416-1jrbu8ox	60	40	workers	worker	NNS
cord-258416-1jrbu8ox	60	41	fighting	fight	VBG
cord-258416-1jrbu8ox	60	42	against	against	IN
cord-258416-1jrbu8ox	60	43	coronavirus	coronavirus	NN
cord-258416-1jrbu8ox	60	44	disease	disease	NN
cord-258416-1jrbu8ox	60	45	2019	2019	CD
cord-258416-1jrbu8ox	60	46	Occupational	Occupational	NNP
cord-258416-1jrbu8ox	60	47	skin	skin	NN
cord-258416-1jrbu8ox	60	48	disease	disease	NN
cord-258416-1jrbu8ox	60	49	among	among	IN
cord-258416-1jrbu8ox	60	50	health	health	NN
cord-258416-1jrbu8ox	60	51	care	care	NN
cord-258416-1jrbu8ox	60	52	workers	worker	NNS
cord-258416-1jrbu8ox	60	53	during	during	IN
cord-258416-1jrbu8ox	60	54	the	the	DT
cord-258416-1jrbu8ox	60	55	coronavirus	coronavirus	NN
cord-258416-1jrbu8ox	60	56	(	(	-LRB-
cord-258416-1jrbu8ox	60	57	COVID-19	covid-19	VB
cord-258416-1jrbu8ox	60	58	)	)	-RRB-
cord-258416-1jrbu8ox	60	59	epidemic	epidemic	NN
cord-258416-1jrbu8ox	60	60	6	6	CD
cord-258416-1jrbu8ox	60	61	NICE	nice	JJ
cord-258416-1jrbu8ox	60	62	guideline	guideline	NN
cord-258416-1jrbu8ox	60	63	[	[	-LRB-
cord-258416-1jrbu8ox	60	64	NG169	ng169	NN
cord-258416-1jrbu8ox	60	65	]	]	-RRB-
cord-258416-1jrbu8ox	61	1	-COVID-19	-COVID-19	.
cord-258416-1jrbu8ox	62	1	rapid	rapid	JJ
cord-258416-1jrbu8ox	62	2	guideline	guideline	NN
cord-258416-1jrbu8ox	62	3	:	:	:
cord-258416-1jrbu8ox	62	4	dermatological	dermatological	JJ
cord-258416-1jrbu8ox	62	5	conditions	condition	NNS
cord-258416-1jrbu8ox	62	6	treated	treat	VBN
cord-258416-1jrbu8ox	62	7	with	with	IN
cord-258416-1jrbu8ox	62	8	drugs	drug	NNS
cord-258416-1jrbu8ox	62	9	affecting	affect	VBG
cord-258416-1jrbu8ox	62	10	the	the	DT
cord-258416-1jrbu8ox	62	11	immune	immune	JJ
cord-258416-1jrbu8ox	62	12	response	response	NN
cord-258416-1jrbu8ox	62	13	British	British	NNP
cord-258416-1jrbu8ox	62	14	Association	Association	NNP
cord-258416-1jrbu8ox	62	15	of	of	IN
cord-258416-1jrbu8ox	62	16	Dermatologists	Dermatologists	NNPS
cord-258416-1jrbu8ox	62	17	(	(	-LRB-
cord-258416-1jrbu8ox	62	18	BAD	bad	RB
cord-258416-1jrbu8ox	62	19	)	)	-RRB-
cord-258416-1jrbu8ox	62	20	-Advice	-Advice	NFP
cord-258416-1jrbu8ox	62	21	for	for	IN
cord-258416-1jrbu8ox	62	22	Dermatology	Dermatology	NNP
cord-258416-1jrbu8ox	62	23	HCPs	HCPs	NNP
cord-258416-1jrbu8ox	62	24	COVID-19	COVID-19	NNP
cord-258416-1jrbu8ox	62	25	and	and	CC
cord-258416-1jrbu8ox	62	26	the	the	DT
cord-258416-1jrbu8ox	62	27	use	use	NN
cord-258416-1jrbu8ox	62	28	of	of	IN
cord-258416-1jrbu8ox	62	29	immunomodulatory	immunomodulatory	JJ
cord-258416-1jrbu8ox	62	30	and	and	CC
cord-258416-1jrbu8ox	62	31	biologic	biologic	JJ
cord-258416-1jrbu8ox	62	32	agents	agent	NNS
cord-258416-1jrbu8ox	62	33	for	for	IN
cord-258416-1jrbu8ox	62	34	severe	severe	JJ
cord-258416-1jrbu8ox	62	35	cutaneous	cutaneous	JJ
cord-258416-1jrbu8ox	62	36	disease	disease	NN
cord-258416-1jrbu8ox	62	37	:	:	:
cord-258416-1jrbu8ox	63	1	An	an	DT
cord-258416-1jrbu8ox	63	2	Australia	Australia	NNP
cord-258416-1jrbu8ox	63	3	/	/	SYM
cord-258416-1jrbu8ox	63	4	New	New	NNP
cord-258416-1jrbu8ox	63	5	Zealand	Zealand	NNP
cord-258416-1jrbu8ox	63	6	consensus	consensus	NN
cord-258416-1jrbu8ox	63	7	statement	statement	NN
cord-258416-1jrbu8ox	63	8	Azulay-	Azulay-	NNP
cord-258416-1jrbu8ox	64	1	Abulafia	Abulafia	NNP
cord-258416-1jrbu8ox	64	2	L.	L.	NNP
cord-258416-1jrbu8ox	64	3	Zika	Zika	NNP
cord-258416-1jrbu8ox	64	4	,	,	,
cord-258416-1jrbu8ox	64	5	chikungunya	chikungunya	NN
cord-258416-1jrbu8ox	64	6	,	,	,
cord-258416-1jrbu8ox	64	7	and	and	CC
cord-258416-1jrbu8ox	64	8	dengue	dengue	NN
cord-258416-1jrbu8ox	64	9	infections	infection	NNS
cord-258416-1jrbu8ox	64	10	as	as	IN
cord-258416-1jrbu8ox	64	11	exacerbating	exacerbate	VBG
cord-258416-1jrbu8ox	64	12	factors	factor	NNS
cord-258416-1jrbu8ox	64	13	of	of	IN
cord-258416-1jrbu8ox	64	14	psoriasis	psoriasis	NN
cord-258416-1jrbu8ox	64	15	in	in	IN
cord-258416-1jrbu8ox	64	16	patients	patient	NNS
cord-258416-1jrbu8ox	64	17	receiving	receive	VBG
cord-258416-1jrbu8ox	64	18	biological	biological	JJ
cord-258416-1jrbu8ox	64	19	therapy	therapy	NN
cord-258416-1jrbu8ox	64	20	COVID-19	covid-19	NN
cord-258416-1jrbu8ox	64	21	and	and	CC
cord-258416-1jrbu8ox	64	22	psoriasis	psoriasis	NN
cord-258416-1jrbu8ox	64	23	:	:	:
cord-258416-1jrbu8ox	64	24	is	be	VBZ
cord-258416-1jrbu8ox	64	25	it	-PRON-	PRP
cord-258416-1jrbu8ox	64	26	time	time	NN
cord-258416-1jrbu8ox	64	27	to	to	TO
cord-258416-1jrbu8ox	64	28	limit	limit	VB
cord-258416-1jrbu8ox	64	29	treatment	treatment	NN
cord-258416-1jrbu8ox	64	30	with	with	IN
cord-258416-1jrbu8ox	64	31	immunosuppressants	immunosuppressant	NNS
cord-258416-1jrbu8ox	64	32	?	?	.
cord-258416-1jrbu8ox	65	1	A	a	DT
cord-258416-1jrbu8ox	65	2	call	call	NN
cord-258416-1jrbu8ox	65	3	for	for	IN
cord-258416-1jrbu8ox	65	4	action	action	NN
cord-258416-1jrbu8ox	65	5	Should	Should	MD
cord-258416-1jrbu8ox	65	6	biologics	biologic	NNS
cord-258416-1jrbu8ox	65	7	for	for	IN
cord-258416-1jrbu8ox	65	8	psoriasis	psoriasis	NN
cord-258416-1jrbu8ox	65	9	be	be	VB
cord-258416-1jrbu8ox	65	10	interrupted	interrupt	VBN
cord-258416-1jrbu8ox	65	11	in	in	IN
cord-258416-1jrbu8ox	65	12	the	the	DT
cord-258416-1jrbu8ox	65	13	era	era	NN
cord-258416-1jrbu8ox	65	14	of	of	IN
cord-258416-1jrbu8ox	65	15	COVID-19	COVID-19	NNP
cord-258416-1jrbu8ox	65	16	?	?	.
cord-258416-1jrbu8ox	66	1	Patients	patient	NNS
cord-258416-1jrbu8ox	66	2	with	with	IN
cord-258416-1jrbu8ox	66	3	rare	rare	JJ
cord-258416-1jrbu8ox	66	4	skin	skin	NN
cord-258416-1jrbu8ox	66	5	diseases	disease	NNS
cord-258416-1jrbu8ox	66	6	and	and	CC
cord-258416-1jrbu8ox	66	7	COVID-19	COVID-19	NNP
cord-258416-1jrbu8ox	66	8	European	European	NNP
cord-258416-1jrbu8ox	66	9	Task	Task	NNP
cord-258416-1jrbu8ox	66	10	Force	Force	NNP
cord-258416-1jrbu8ox	66	11	on	on	IN
cord-258416-1jrbu8ox	66	12	Atopic	Atopic	NNP
cord-258416-1jrbu8ox	66	13	Dermatitis	Dermatitis	NNP
cord-258416-1jrbu8ox	66	14	(	(	-LRB-
cord-258416-1jrbu8ox	66	15	ETFAD	ETFAD	NNP
cord-258416-1jrbu8ox	66	16	)	)	-RRB-
cord-258416-1jrbu8ox	66	17	statement	statement	NN
cord-258416-1jrbu8ox	66	18	on	on	IN
cord-258416-1jrbu8ox	66	19	severe	severe	JJ
cord-258416-1jrbu8ox	66	20	acute	acute	JJ
cord-258416-1jrbu8ox	66	21	respiratory	respiratory	JJ
cord-258416-1jrbu8ox	66	22	syndrome	syndrome	NN
cord-258416-1jrbu8ox	66	23	coronavirus	coronavirus	NN
cord-258416-1jrbu8ox	66	24	2	2	CD
cord-258416-1jrbu8ox	67	1	(	(	-LRB-
cord-258416-1jrbu8ox	67	2	SARS	SARS	NNP
cord-258416-1jrbu8ox	67	3	-	-	HYPH
cord-258416-1jrbu8ox	67	4	Cov-2)-infection	Cov-2)-infection	NNP
cord-258416-1jrbu8ox	67	5	and	and	CC
cord-258416-1jrbu8ox	67	6	atopic	atopic	JJ
cord-258416-1jrbu8ox	67	7	dermatitis	dermatitis	NN
cord-258416-1jrbu8ox	67	8	Guidance	Guidance	NNP
cord-258416-1jrbu8ox	67	9	from	from	IN
cord-258416-1jrbu8ox	67	10	the	the	DT
cord-258416-1jrbu8ox	67	11	EADV	EADV	NNP
cord-258416-1jrbu8ox	67	12	Task	Task	NNP
cord-258416-1jrbu8ox	67	13	Force	Force	NNP
cord-258416-1jrbu8ox	67	14	Autoimmune	Autoimmune	NNP
cord-258416-1jrbu8ox	67	15	Blistering	blister	VBG
cord-258416-1jrbu8ox	67	16	Diseases	disease	NNS
cord-258416-1jrbu8ox	67	17	during	during	IN
cord-258416-1jrbu8ox	67	18	the	the	DT
cord-258416-1jrbu8ox	67	19	COVID-19	COVID-19	NNP
cord-258416-1jrbu8ox	67	20	pandemic	pandemic	NN
cord-258416-1jrbu8ox	67	21	Expert	expert	NN
cord-258416-1jrbu8ox	67	22	recommendations	recommendation	NNS
cord-258416-1jrbu8ox	67	23	for	for	IN
cord-258416-1jrbu8ox	67	24	the	the	DT
cord-258416-1jrbu8ox	67	25	management	management	NN
cord-258416-1jrbu8ox	67	26	of	of	IN
cord-258416-1jrbu8ox	67	27	autoimmune	autoimmune	JJ
cord-258416-1jrbu8ox	67	28	bullous	bullous	JJ
cord-258416-1jrbu8ox	67	29	diseases	disease	NNS
cord-258416-1jrbu8ox	67	30	during	during	IN
cord-258416-1jrbu8ox	67	31	the	the	DT
cord-258416-1jrbu8ox	67	32	COVID-19	COVID-19	NNP
cord-258416-1jrbu8ox	67	33	pandemic	pandemic	NN
cord-258416-1jrbu8ox	67	34	Treatment	Treatment	NNP
cord-258416-1jrbu8ox	67	35	considerations	consideration	NNS
cord-258416-1jrbu8ox	67	36	for	for	IN
cord-258416-1jrbu8ox	67	37	patients	patient	NNS
cord-258416-1jrbu8ox	67	38	with	with	IN
cord-258416-1jrbu8ox	67	39	pemphigus	pemphigus	NNP
cord-258416-1jrbu8ox	67	40	during	during	IN
cord-258416-1jrbu8ox	67	41	the	the	DT
cord-258416-1jrbu8ox	67	42	COVID-19	COVID-19	NNP
cord-258416-1jrbu8ox	67	43	pandemic	pandemic	NN
cord-258416-1jrbu8ox	68	1	The	the	DT
cord-258416-1jrbu8ox	68	2	COVID-19	covid-19	CD
cord-258416-1jrbu8ox	68	3	outbreak	outbreak	NN
cord-258416-1jrbu8ox	68	4	and	and	CC
cord-258416-1jrbu8ox	68	5	rheumatologic	rheumatologic	JJ
cord-258416-1jrbu8ox	68	6	skin	skin	NN
cord-258416-1jrbu8ox	68	7	diseases	disease	NNS
cord-258416-1jrbu8ox	68	8	American	American	NNP
cord-258416-1jrbu8ox	68	9	College	College	NNP
cord-258416-1jrbu8ox	68	10	of	of	IN
cord-258416-1jrbu8ox	68	11	Rheumatology	Rheumatology	NNP
cord-258416-1jrbu8ox	69	1	guidance	guidance	NN
cord-258416-1jrbu8ox	69	2	for	for	IN
cord-258416-1jrbu8ox	69	3	the	the	DT
cord-258416-1jrbu8ox	69	4	management	management	NN
cord-258416-1jrbu8ox	69	5	of	of	IN
cord-258416-1jrbu8ox	69	6	adult	adult	NN
cord-258416-1jrbu8ox	69	7	patients	patient	NNS
cord-258416-1jrbu8ox	69	8	with	with	IN
cord-258416-1jrbu8ox	69	9	rheumatic	rheumatic	JJ
cord-258416-1jrbu8ox	69	10	disease	disease	NN
cord-258416-1jrbu8ox	69	11	during	during	IN
cord-258416-1jrbu8ox	69	12	the	the	DT
cord-258416-1jrbu8ox	69	13	COVID-19	covid-19	CD
cord-258416-1jrbu8ox	69	14	pandemic	pandemic	NN
cord-258416-1jrbu8ox	69	15	Systemic	systemic	JJ
cord-258416-1jrbu8ox	69	16	immunosuppressive	immunosuppressive	JJ
cord-258416-1jrbu8ox	69	17	therapy	therapy	NN
cord-258416-1jrbu8ox	69	18	for	for	IN
cord-258416-1jrbu8ox	69	19	inflammatory	inflammatory	JJ
cord-258416-1jrbu8ox	69	20	skin	skin	NN
cord-258416-1jrbu8ox	69	21	diseases	disease	NNS
cord-258416-1jrbu8ox	69	22	in	in	IN
cord-258416-1jrbu8ox	69	23	children	child	NNS
cord-258416-1jrbu8ox	69	24	:	:	:
cord-258416-1jrbu8ox	70	1	Expert	expert	NN
cord-258416-1jrbu8ox	70	2	consensus	consensus	NN
cord-258416-1jrbu8ox	70	3	-	-	HYPH
cord-258416-1jrbu8ox	70	4	based	base	VBN
cord-258416-1jrbu8ox	70	5	guidance	guidance	NN
cord-258416-1jrbu8ox	70	6	for	for	IN
cord-258416-1jrbu8ox	70	7	clinical	clinical	JJ
cord-258416-1jrbu8ox	70	8	decision	decision	NN
cord-258416-1jrbu8ox	70	9	-	-	HYPH
cord-258416-1jrbu8ox	70	10	making	making	NN
cord-258416-1jrbu8ox	70	11	during	during	IN
cord-258416-1jrbu8ox	70	12	the	the	DT
cord-258416-1jrbu8ox	70	13	COVID-19	COVID-19	NNP
cord-258416-1jrbu8ox	70	14	pandemic	pandemic	NN
cord-258416-1jrbu8ox	70	15	Management	Management	NNP
cord-258416-1jrbu8ox	70	16	of	of	IN
cord-258416-1jrbu8ox	70	17	infantile	infantile	JJ
cord-258416-1jrbu8ox	70	18	hemangiomas	hemangiomas	NN
cord-258416-1jrbu8ox	70	19	during	during	IN
cord-258416-1jrbu8ox	70	20	the	the	DT
cord-258416-1jrbu8ox	70	21	COVID	COVID	NNP
cord-258416-1jrbu8ox	70	22	pandemic	pandemic	NN
cord-258416-1jrbu8ox	70	23	Sebaratnam	Sebaratnam	NNP
cord-258416-1jrbu8ox	70	24	Deshan	Deshan	NNP
cord-258416-1jrbu8ox	70	25	Frank	Frank	NNP
cord-258416-1jrbu8ox	70	26	.	.	.
cord-258416-1jrbu8ox	71	1	Recommendations	recommendation	NNS
cord-258416-1jrbu8ox	71	2	on	on	IN
cord-258416-1jrbu8ox	71	3	dermatologic	dermatologic	JJ
cord-258416-1jrbu8ox	71	4	surgery	surgery	NN
cord-258416-1jrbu8ox	71	5	during	during	IN
cord-258416-1jrbu8ox	71	6	the	the	DT
cord-258416-1jrbu8ox	71	7	COVID-19	COVID-19	NNP
cord-258416-1jrbu8ox	71	8	pandemic	pandemic	NN
cord-258416-1jrbu8ox	71	9	Art	art	NN
cord-258416-1jrbu8ox	71	10	of	of	IN
cord-258416-1jrbu8ox	71	11	performing	perform	VBG
cord-258416-1jrbu8ox	71	12	dermoscopy	dermoscopy	NNS
cord-258416-1jrbu8ox	71	13	during	during	IN
cord-258416-1jrbu8ox	71	14	the	the	DT
cord-258416-1jrbu8ox	71	15	times	time	NNS
cord-258416-1jrbu8ox	71	16	of	of	IN
cord-258416-1jrbu8ox	71	17	coronavirus	coronavirus	NN
cord-258416-1jrbu8ox	71	18	disease	disease	NN
cord-258416-1jrbu8ox	71	19	(	(	-LRB-
cord-258416-1jrbu8ox	71	20	COVID-19	COVID-19	NNP
cord-258416-1jrbu8ox	71	21	)	)	-RRB-
cord-258416-1jrbu8ox	71	22	:	:	:
cord-258416-1jrbu8ox	72	1	simple	simple	JJ
cord-258416-1jrbu8ox	72	2	change	change	NN
cord-258416-1jrbu8ox	72	3	in	in	IN
cord-258416-1jrbu8ox	72	4	approach	approach	NN
cord-258416-1jrbu8ox	72	5	can	can	MD
cord-258416-1jrbu8ox	72	6	save	save	VB
cord-258416-1jrbu8ox	72	7	the	the	DT
cord-258416-1jrbu8ox	72	8	day	day	NN
cord-258416-1jrbu8ox	72	9	!	!	.
cord-258416-1jrbu8ox	73	1	Royal	Royal	NNP
cord-258416-1jrbu8ox	73	2	College	College	NNP
cord-258416-1jrbu8ox	73	3	of	of	IN
cord-258416-1jrbu8ox	73	4	Radiologists	Radiologists	NNPS
cord-258416-1jrbu8ox	73	5	-Non	-Non	:
cord-258416-1jrbu8ox	73	6	-	-	HYPH
cord-258416-1jrbu8ox	73	7	melanoma	melanoma	NN
cord-258416-1jrbu8ox	73	8	skin	skin	NN
cord-258416-1jrbu8ox	73	9	cancer	cancer	NN
cord-258416-1jrbu8ox	73	10	(	(	-LRB-
cord-258416-1jrbu8ox	73	11	NMSC	NMSC	NNP
cord-258416-1jrbu8ox	73	12	)	)	-RRB-
cord-258416-1jrbu8ox	73	13	and	and	CC
cord-258416-1jrbu8ox	73	14	COVID-19	COVID-19	NNP
cord-258416-1jrbu8ox	73	15	(	(	-LRB-
cord-258416-1jrbu8ox	73	16	PDF	PDF	NNP
cord-258416-1jrbu8ox	73	17	)	)	-RRB-
cord-258416-1jrbu8ox	73	18	Royal	Royal	NNP
cord-258416-1jrbu8ox	73	19	College	College	NNP
cord-258416-1jrbu8ox	73	20	of	of	IN
cord-258416-1jrbu8ox	73	21	Radiologists	Radiologists	NNPS
cord-258416-1jrbu8ox	73	22	-Guidelines	-guideline	VBZ
cord-258416-1jrbu8ox	73	23	for	for	IN
cord-258416-1jrbu8ox	73	24	follow	follow	NN
cord-258416-1jrbu8ox	73	25	-	-	HYPH
cord-258416-1jrbu8ox	73	26	up	up	NN
cord-258416-1jrbu8ox	73	27	and	and	CC
cord-258416-1jrbu8ox	73	28	SACT	SACT	NNP
cord-258416-1jrbu8ox	73	29	for	for	IN
cord-258416-1jrbu8ox	73	30	melanoma	melanoma	NN
cord-258416-1jrbu8ox	73	31	during	during	IN
cord-258416-1jrbu8ox	73	32	COVID-19	covid-19	JJ
cord-258416-1jrbu8ox	73	33	pandemic	pandemic	NN
cord-258416-1jrbu8ox	73	34	(	(	-LRB-
cord-258416-1jrbu8ox	73	35	PDF	PDF	NNP
cord-258416-1jrbu8ox	73	36	)	)	-RRB-
cord-258416-1jrbu8ox	73	37	Management	Management	NNP
cord-258416-1jrbu8ox	73	38	of	of	IN
cord-258416-1jrbu8ox	73	39	advanced	advanced	JJ
cord-258416-1jrbu8ox	73	40	melanoma	melanoma	NN
cord-258416-1jrbu8ox	73	41	in	in	IN
cord-258416-1jrbu8ox	73	42	the	the	DT
cord-258416-1jrbu8ox	73	43	COVID-19	covid-19	NN
cord-258416-1jrbu8ox	73	44	the	the	DT
cord-258416-1jrbu8ox	73	45	International	International	NNP
cord-258416-1jrbu8ox	73	46	Society	Society	NNP
cord-258416-1jrbu8ox	73	47	of	of	IN
cord-258416-1jrbu8ox	73	48	Dermatology	Dermatology	NNP
cord-258416-1jrbu8ox	73	49	United	United	NNP
cord-258416-1jrbu8ox	73	50	States	States	NNP
cord-258416-1jrbu8ox	73	51	Cutaneous	Cutaneous	NNP
cord-258416-1jrbu8ox	73	52	Lymphoma	Lymphoma	NNP
cord-258416-1jrbu8ox	73	53	Consortium	Consortium	NNP
cord-258416-1jrbu8ox	73	54	recommendations	recommendation	NNS
cord-258416-1jrbu8ox	73	55	for	for	IN
cord-258416-1jrbu8ox	73	56	treatment	treatment	NN
cord-258416-1jrbu8ox	73	57	of	of	IN
cord-258416-1jrbu8ox	73	58	cutaneous	cutaneous	JJ
cord-258416-1jrbu8ox	73	59	lymphomas	lymphoma	NNS
cord-258416-1jrbu8ox	73	60	during	during	IN
cord-258416-1jrbu8ox	73	61	the	the	DT
cord-258416-1jrbu8ox	73	62	COVID-19	covid-19	JJ
cord-258416-1jrbu8ox	73	63	pandemic	pandemic	NN
cord-258416-1jrbu8ox	73	64	What	what	WP
cord-258416-1jrbu8ox	73	65	are	be	VBP
cord-258416-1jrbu8ox	73	66	we	-PRON-	PRP
cord-258416-1jrbu8ox	73	67	doing	do	VBG
cord-258416-1jrbu8ox	73	68	in	in	IN
cord-258416-1jrbu8ox	73	69	the	the	DT
cord-258416-1jrbu8ox	73	70	dermatology	dermatology	NN
cord-258416-1jrbu8ox	73	71	outpatient	outpatient	NN
cord-258416-1jrbu8ox	73	72	department	department	NN
cord-258416-1jrbu8ox	73	73	amidst	amidst	IN
cord-258416-1jrbu8ox	73	74	the	the	DT
cord-258416-1jrbu8ox	73	75	raging	raging	NN
cord-258416-1jrbu8ox	73	76	of	of	IN
cord-258416-1jrbu8ox	73	77	the	the	DT
cord-258416-1jrbu8ox	73	78	2019	2019	CD
cord-258416-1jrbu8ox	73	79	novel	novel	NN
cord-258416-1jrbu8ox	73	80	coronavirus	coronavirus	NN
cord-258416-1jrbu8ox	73	81	?	?	.
cord-258416-1jrbu8ox	74	1	American	American	NNP
cord-258416-1jrbu8ox	74	2	Academy	Academy	NNP
cord-258416-1jrbu8ox	74	3	of	of	IN
cord-258416-1jrbu8ox	74	4	Dermatology	Dermatology	NNP
cord-258416-1jrbu8ox	75	1	(	(	-LRB-
cord-258416-1jrbu8ox	75	2	AAD	AAD	NNP
cord-258416-1jrbu8ox	75	3	)	)	-RRB-
cord-258416-1jrbu8ox	75	4	-Managing	-Managing	.
cord-258416-1jrbu8ox	76	1	your	-PRON-	PRP$
cord-258416-1jrbu8ox	76	2	practice	practice	NN
cord-258416-1jrbu8ox	76	3	through	through	IN
cord-258416-1jrbu8ox	76	4	the	the	DT
cord-258416-1jrbu8ox	76	5	COVID-19	covid-19	JJ
cord-258416-1jrbu8ox	76	6	outbreak	outbreak	NN
cord-258416-1jrbu8ox	76	7	Recommendations	Recommendations	NNPS
cord-258416-1jrbu8ox	76	8	for	for	IN
cord-258416-1jrbu8ox	76	9	phototherapy	phototherapy	NN
cord-258416-1jrbu8ox	76	10	during	during	IN
cord-258416-1jrbu8ox	76	11	the	the	DT
cord-258416-1jrbu8ox	76	12	COVID-19	covid-19	CD
cord-258416-1jrbu8ox	76	13	pandemic	pandemic	NN
cord-258416-1jrbu8ox	76	14	The	the	DT
cord-258416-1jrbu8ox	76	15	coronavirus	coronavirus	NN
cord-258416-1jrbu8ox	76	16	(	(	-LRB-
cord-258416-1jrbu8ox	76	17	COVID-19	covid-19	VB
cord-258416-1jrbu8ox	76	18	)	)	-RRB-
cord-258416-1jrbu8ox	76	19	epidemic	epidemic	NN
cord-258416-1jrbu8ox	76	20	and	and	CC
cord-258416-1jrbu8ox	76	21	patient	patient	NN
cord-258416-1jrbu8ox	76	22	safety	safety	NN
cord-258416-1jrbu8ox	76	23	Acute	acute	JJ
cord-258416-1jrbu8ox	76	24	hemorrhagic	hemorrhagic	JJ
cord-258416-1jrbu8ox	76	25	edema	edema	NN
cord-258416-1jrbu8ox	76	26	of	of	IN
cord-258416-1jrbu8ox	76	27	infancy	infancy	NN
cord-258416-1jrbu8ox	76	28	after	after	IN
cord-258416-1jrbu8ox	76	29	Coronavirus	Coronavirus	NNP
cord-258416-1jrbu8ox	76	30	infection	infection	NN
cord-258416-1jrbu8ox	76	31	with	with	IN
cord-258416-1jrbu8ox	76	32	recurrent	recurrent	JJ
cord-258416-1jrbu8ox	76	33	rash	rash	NN
cord-258416-1jrbu8ox	76	34	.	.	.
cord-258416-1jrbu8ox	77	1	Case	Case	NNP
cord-258416-1jrbu8ox	77	2	Rep	Rep	NNP
cord-258416-1jrbu8ox	77	3	Pediatr	Pediatr	NNP
cord-258416-1jrbu8ox	77	4	Clinical	clinical	JJ
cord-258416-1jrbu8ox	77	5	characteristics	characteristic	NNS
cord-258416-1jrbu8ox	77	6	of	of	IN
cord-258416-1jrbu8ox	77	7	children	child	NNS
cord-258416-1jrbu8ox	77	8	with	with	IN
cord-258416-1jrbu8ox	77	9	viral	viral	JJ
cord-258416-1jrbu8ox	77	10	single	single	JJ
cord-258416-1jrbu8ox	77	11	-	-	HYPH
cord-258416-1jrbu8ox	77	12	and	and	CC
cord-258416-1jrbu8ox	77	13	co	co	NNS
cord-258416-1jrbu8ox	77	14	-	-	NNS
cord-258416-1jrbu8ox	77	15	infections	infection	NNS
cord-258416-1jrbu8ox	77	16	and	and	CC
cord-258416-1jrbu8ox	77	17	a	a	DT
cord-258416-1jrbu8ox	77	18	petechial	petechial	JJ
cord-258416-1jrbu8ox	77	19	rash	rash	JJ
cord-258416-1jrbu8ox	77	20	Cutaneous	cutaneous	JJ
cord-258416-1jrbu8ox	77	21	manifestations	manifestation	NNS
cord-258416-1jrbu8ox	77	22	in	in	IN
cord-258416-1jrbu8ox	77	23	COVID-19	COVID-19	NNP
cord-258416-1jrbu8ox	77	24	:	:	:
cord-258416-1jrbu8ox	77	25	a	a	DT
cord-258416-1jrbu8ox	77	26	first	first	JJ
cord-258416-1jrbu8ox	77	27	perspective	perspective	NN
cord-258416-1jrbu8ox	77	28	Comment	comment	NN
cord-258416-1jrbu8ox	77	29	on	on	IN
cord-258416-1jrbu8ox	77	30	'	'	``
cord-258416-1jrbu8ox	77	31	Cutaneous	cutaneous	JJ
cord-258416-1jrbu8ox	77	32	manifestations	manifestation	NNS
cord-258416-1jrbu8ox	77	33	in	in	IN
cord-258416-1jrbu8ox	77	34	COVID-19	COVID-19	NNP
cord-258416-1jrbu8ox	77	35	:	:	:
cord-258416-1jrbu8ox	77	36	a	a	DT
cord-258416-1jrbu8ox	77	37	first	first	JJ
cord-258416-1jrbu8ox	77	38	perspective	perspective	NN
cord-258416-1jrbu8ox	77	39	'	'	''
cord-258416-1jrbu8ox	77	40	by	by	IN
cord-258416-1jrbu8ox	77	41	Recalcati	Recalcati	NNP
cord-258416-1jrbu8ox	77	42	S	S	NNP
cord-258416-1jrbu8ox	77	43	A	A	NNP
cord-258416-1jrbu8ox	77	44	case	case	NN
cord-258416-1jrbu8ox	77	45	of	of	IN
cord-258416-1jrbu8ox	77	46	COVID-19	covid-19	JJ
cord-258416-1jrbu8ox	77	47	pneumonia	pneumonia	NN
cord-258416-1jrbu8ox	77	48	in	in	IN
cord-258416-1jrbu8ox	77	49	a	a	DT
cord-258416-1jrbu8ox	77	50	young	young	JJ
cord-258416-1jrbu8ox	77	51	male	male	NN
cord-258416-1jrbu8ox	77	52	with	with	IN
cord-258416-1jrbu8ox	77	53	full	full	JJ
cord-258416-1jrbu8ox	77	54	body	body	NN
cord-258416-1jrbu8ox	77	55	rash	rash	NN
cord-258416-1jrbu8ox	77	56	as	as	IN
cord-258416-1jrbu8ox	77	57	a	a	DT
cord-258416-1jrbu8ox	77	58	presenting	present	VBG
cord-258416-1jrbu8ox	77	59	symptom	symptom	NN
cord-258416-1jrbu8ox	77	60	Rash	rash	NN
cord-258416-1jrbu8ox	77	61	as	as	IN
cord-258416-1jrbu8ox	77	62	a	a	DT
cord-258416-1jrbu8ox	77	63	clinical	clinical	JJ
cord-258416-1jrbu8ox	77	64	manifestation	manifestation	NN
cord-258416-1jrbu8ox	77	65	of	of	IN
cord-258416-1jrbu8ox	77	66	COVID19	COVID19	NNP
cord-258416-1jrbu8ox	77	67	.	.	.
cord-258416-1jrbu8ox	78	1	Photographs	photograph	NNS
cord-258416-1jrbu8ox	78	2	of	of	IN
cord-258416-1jrbu8ox	78	3	a	a	DT
cord-258416-1jrbu8ox	78	4	patient	patient	NN
cord-258416-1jrbu8ox	79	1	A	a	DT
cord-258416-1jrbu8ox	79	2	distinctive	distinctive	JJ
cord-258416-1jrbu8ox	79	3	skin	skin	NN
cord-258416-1jrbu8ox	79	4	rash	rash	NN
cord-258416-1jrbu8ox	79	5	associated	associate	VBN
cord-258416-1jrbu8ox	79	6	with	with	IN
cord-258416-1jrbu8ox	79	7	coronavirus	coronavirus	NN
cord-258416-1jrbu8ox	79	8	disease	disease	NN
cord-258416-1jrbu8ox	79	9	2019	2019	CD
cord-258416-1jrbu8ox	79	10	?	?	.
cord-258416-1jrbu8ox	80	1	Urticarial	urticarial	JJ
cord-258416-1jrbu8ox	80	2	eruption	eruption	NN
cord-258416-1jrbu8ox	80	3	in	in	IN
cord-258416-1jrbu8ox	80	4	COVID-19	COVID-19	NNP
cord-258416-1jrbu8ox	80	5	infection	infection	NN
cord-258416-1jrbu8ox	80	6	Comment	Comment	NNP
cord-258416-1jrbu8ox	80	7	on	on	IN
cord-258416-1jrbu8ox	80	8	:	:	:
cord-258416-1jrbu8ox	80	9	Cutaneous	cutaneous	JJ
cord-258416-1jrbu8ox	80	10	manifestations	manifestation	NNS
cord-258416-1jrbu8ox	80	11	in	in	IN
cord-258416-1jrbu8ox	80	12	COVID-19	COVID-19	NNP
cord-258416-1jrbu8ox	80	13	:	:	:
cord-258416-1jrbu8ox	80	14	a	a	DT
cord-258416-1jrbu8ox	80	15	first	first	JJ
cord-258416-1jrbu8ox	80	16	perspective	perspective	NN
cord-258416-1jrbu8ox	80	17	.	.	.
cord-258416-1jrbu8ox	81	1	Safety	safety	NN
cord-258416-1jrbu8ox	81	2	concerns	concern	NNS
cord-258416-1jrbu8ox	81	3	of	of	IN
cord-258416-1jrbu8ox	81	4	clinical	clinical	JJ
cord-258416-1jrbu8ox	81	5	images	image	NNS
cord-258416-1jrbu8ox	81	6	and	and	CC
cord-258416-1jrbu8ox	81	7	skin	skin	NN
cord-258416-1jrbu8ox	81	8	biopsies	biopsy	NNS
cord-258416-1jrbu8ox	81	9	Cutaneous	cutaneous	JJ
cord-258416-1jrbu8ox	81	10	manifestations	manifestation	NNS
cord-258416-1jrbu8ox	81	11	in	in	IN
cord-258416-1jrbu8ox	81	12	COVID-19	COVID-19	NNP
cord-258416-1jrbu8ox	81	13	:	:	:
cord-258416-1jrbu8ox	81	14	a	a	DT
cord-258416-1jrbu8ox	81	15	new	new	JJ
cord-258416-1jrbu8ox	81	16	contribution	contribution	NN
cord-258416-1jrbu8ox	81	17	Varicella	varicella	NN
cord-258416-1jrbu8ox	81	18	-	-	HYPH
cord-258416-1jrbu8ox	81	19	like	like	JJ
cord-258416-1jrbu8ox	81	20	exanthem	exanthem	NNP
cord-258416-1jrbu8ox	81	21	as	as	IN
cord-258416-1jrbu8ox	81	22	a	a	DT
cord-258416-1jrbu8ox	81	23	specific	specific	JJ
cord-258416-1jrbu8ox	81	24	COVID-19-associated	covid-19-associated	JJ
cord-258416-1jrbu8ox	81	25	skin	skin	NN
cord-258416-1jrbu8ox	81	26	manifestation	manifestation	NN
cord-258416-1jrbu8ox	81	27	:	:	:
cord-258416-1jrbu8ox	81	28	multicenter	multicenter	JJ
cord-258416-1jrbu8ox	81	29	case	case	NN
cord-258416-1jrbu8ox	81	30	series	series	NN
cord-258416-1jrbu8ox	81	31	of	of	IN
cord-258416-1jrbu8ox	81	32	22	22	CD
cord-258416-1jrbu8ox	81	33	patients	patient	NNS
cord-258416-1jrbu8ox	81	34	Clinical	clinical	JJ
cord-258416-1jrbu8ox	81	35	and	and	CC
cord-258416-1jrbu8ox	81	36	histological	histological	JJ
cord-258416-1jrbu8ox	81	37	characterization	characterization	NN
cord-258416-1jrbu8ox	81	38	of	of	IN
cord-258416-1jrbu8ox	81	39	vesicular	vesicular	JJ
cord-258416-1jrbu8ox	81	40	COVID-19	COVID-19	NNP
cord-258416-1jrbu8ox	81	41	rashes	rash	NNS
cord-258416-1jrbu8ox	81	42	:	:	:
cord-258416-1jrbu8ox	81	43	a	a	DT
cord-258416-1jrbu8ox	81	44	prospective	prospective	JJ
cord-258416-1jrbu8ox	81	45	study	study	NN
cord-258416-1jrbu8ox	81	46	in	in	IN
cord-258416-1jrbu8ox	81	47	a	a	DT
cord-258416-1jrbu8ox	81	48	tertiary	tertiary	JJ
cord-258416-1jrbu8ox	81	49	care	care	NN
cord-258416-1jrbu8ox	81	50	hospital	hospital	NN
cord-258416-1jrbu8ox	81	51	Marzano	Marzano	NNP
cord-258416-1jrbu8ox	81	52	Angelo	Angelo	NNP
cord-258416-1jrbu8ox	81	53	V.	V.	NNP
cord-258416-1jrbu8ox	81	54	Varicella	Varicella	NNP
cord-258416-1jrbu8ox	81	55	-	-	HYPH
cord-258416-1jrbu8ox	81	56	like	like	IN
cord-258416-1jrbu8ox	81	57	exanthem	exanthem	NN
cord-258416-1jrbu8ox	81	58	associated	associate	VBN
cord-258416-1jrbu8ox	81	59	with	with	IN
cord-258416-1jrbu8ox	81	60	COVID-19	COVID-19	NNP
cord-258416-1jrbu8ox	81	61	in	in	IN
cord-258416-1jrbu8ox	81	62	an	an	DT
cord-258416-1jrbu8ox	81	63	8-yearold	8-yearold	CD
cord-258416-1jrbu8ox	81	64	girl	girl	NN
cord-258416-1jrbu8ox	81	65	:	:	:
cord-258416-1jrbu8ox	81	66	a	a	DT
cord-258416-1jrbu8ox	81	67	diagnostic	diagnostic	JJ
cord-258416-1jrbu8ox	81	68	clue	clue	NN
cord-258416-1jrbu8ox	81	69	?	?	.
cord-258416-1jrbu8ox	82	1	Acute	acute	JJ
cord-258416-1jrbu8ox	82	2	acro	acro	NN
cord-258416-1jrbu8ox	82	3	-	-	HYPH
cord-258416-1jrbu8ox	82	4	ischemia	ischemia	NN
cord-258416-1jrbu8ox	82	5	in	in	IN
cord-258416-1jrbu8ox	82	6	the	the	DT
cord-258416-1jrbu8ox	82	7	child	child	NN
cord-258416-1jrbu8ox	82	8	at	at	IN
cord-258416-1jrbu8ox	82	9	the	the	DT
cord-258416-1jrbu8ox	82	10	time	time	NN
cord-258416-1jrbu8ox	82	11	of	of	IN
cord-258416-1jrbu8ox	82	12	COVID-19	COVID-19	NNP
cord-258416-1jrbu8ox	82	13	.	.	.
cord-258416-1jrbu8ox	83	1	Dermatol	Dermatol	NNP
cord-258416-1jrbu8ox	83	2	Pediatr	Pediatr	NNP
cord-258416-1jrbu8ox	83	3	.	.	.
cord-258416-1jrbu8ox	84	1	Online	online	RB
cord-258416-1jrbu8ox	84	2	ahead	ahead	RB
cord-258416-1jrbu8ox	84	3	of	of	IN
cord-258416-1jrbu8ox	84	4	print	print	NN
cord-258416-1jrbu8ox	84	5	A	a	DT
cord-258416-1jrbu8ox	84	6	case	case	NN
cord-258416-1jrbu8ox	84	7	of	of	IN
cord-258416-1jrbu8ox	84	8	COVID-19	COVID-19	NNP
cord-258416-1jrbu8ox	84	9	presenting	present	VBG
cord-258416-1jrbu8ox	84	10	in	in	IN
cord-258416-1jrbu8ox	84	11	clinical	clinical	JJ
cord-258416-1jrbu8ox	84	12	picture	picture	NN
cord-258416-1jrbu8ox	84	13	resembling	resemble	VBG
cord-258416-1jrbu8ox	84	14	chilblains	chilblain	NNS
cord-258416-1jrbu8ox	84	15	disease	disease	NN
cord-258416-1jrbu8ox	84	16	.	.	.
cord-258416-1jrbu8ox	85	1	First	first	JJ
cord-258416-1jrbu8ox	85	2	report	report	NN
cord-258416-1jrbu8ox	85	3	from	from	IN
cord-258416-1jrbu8ox	85	4	the	the	DT
cord-258416-1jrbu8ox	85	5	Middle	Middle	NNP
cord-258416-1jrbu8ox	85	6	East	East	NNP
cord-258416-1jrbu8ox	86	1	A	a	DT
cord-258416-1jrbu8ox	86	2	new	new	JJ
cord-258416-1jrbu8ox	86	3	vasculitis	vasculitis	NN
cord-258416-1jrbu8ox	86	4	at	at	IN
cord-258416-1jrbu8ox	86	5	the	the	DT
cord-258416-1jrbu8ox	86	6	time	time	NN
cord-258416-1jrbu8ox	86	7	of	of	IN
cord-258416-1jrbu8ox	87	1	COVID-19	COVID-19	NNP
cord-258416-1jrbu8ox	87	2	COVID-19	covid-19	CD
cord-258416-1jrbu8ox	87	3	)	)	-RRB-
cord-258416-1jrbu8ox	87	4	infection	infection	NN
cord-258416-1jrbu8ox	87	5	induced	induce	VBD
cord-258416-1jrbu8ox	87	6	chilblains	chilblain	NNS
cord-258416-1jrbu8ox	87	7	:	:	:
cord-258416-1jrbu8ox	87	8	a	a	DT
cord-258416-1jrbu8ox	87	9	case	case	NN
cord-258416-1jrbu8ox	87	10	report	report	NN
cord-258416-1jrbu8ox	87	11	with	with	IN
cord-258416-1jrbu8ox	87	12	histopathological	histopathological	NNP
cord-258416-1jrbu8ox	87	13	findings	finding	NNS
cord-258416-1jrbu8ox	88	1	Mysterious	mysterious	JJ
cord-258416-1jrbu8ox	88	2	Skin	skin	NN
cord-258416-1jrbu8ox	88	3	Condition	condition	NN
cord-258416-1jrbu8ox	88	4	Could	Could	MD
cord-258416-1jrbu8ox	88	5	be	be	VB
cord-258416-1jrbu8ox	88	6	Linked	link	VBN
cord-258416-1jrbu8ox	88	7	to	to	IN
cord-258416-1jrbu8ox	88	8	Coronavirus	Coronavirus	NNP
cord-258416-1jrbu8ox	88	9	,	,	,
cord-258416-1jrbu8ox	88	10	Derms	Derms	NNP
cord-258416-1jrbu8ox	88	11	Say	say	VB
cord-258416-1jrbu8ox	88	12	.	.	.
cord-258416-1jrbu8ox	89	1	Coronavirus	Coronavirus	NNP
cord-258416-1jrbu8ox	89	2	Illinois	Illinois	NNP
cord-258416-1jrbu8ox	89	3	Chilblain	Chilblain	NNP
cord-258416-1jrbu8ox	89	4	-	-	HYPH
cord-258416-1jrbu8ox	89	5	like	like	JJ
cord-258416-1jrbu8ox	89	6	lesions	lesion	NNS
cord-258416-1jrbu8ox	89	7	during	during	IN
cord-258416-1jrbu8ox	89	8	COVID-19	covid-19	CD
cord-258416-1jrbu8ox	89	9	epidemic	epidemic	NN
cord-258416-1jrbu8ox	89	10	:	:	:
cord-258416-1jrbu8ox	89	11	a	a	DT
cord-258416-1jrbu8ox	89	12	preliminary	preliminary	JJ
cord-258416-1jrbu8ox	89	13	study	study	NN
cord-258416-1jrbu8ox	89	14	on	on	IN
cord-258416-1jrbu8ox	89	15	63	63	CD
cord-258416-1jrbu8ox	89	16	patients	patient	NNS
cord-258416-1jrbu8ox	90	1	Chilblains	chilblain	NNS
cord-258416-1jrbu8ox	90	2	are	be	VBP
cord-258416-1jrbu8ox	90	3	a	a	DT
cord-258416-1jrbu8ox	90	4	common	common	JJ
cord-258416-1jrbu8ox	90	5	cutaneous	cutaneous	JJ
cord-258416-1jrbu8ox	90	6	finding	finding	NN
cord-258416-1jrbu8ox	90	7	during	during	IN
cord-258416-1jrbu8ox	90	8	the	the	DT
cord-258416-1jrbu8ox	90	9	COVID-19	COVID-19	NNP
cord-258416-1jrbu8ox	90	10	pandemic	pandemic	NN
cord-258416-1jrbu8ox	90	11	:	:	:
cord-258416-1jrbu8ox	90	12	a	a	DT
cord-258416-1jrbu8ox	90	13	retrospective	retrospective	JJ
cord-258416-1jrbu8ox	90	14	nationwide	nationwide	JJ
cord-258416-1jrbu8ox	90	15	study	study	NN
cord-258416-1jrbu8ox	90	16	from	from	IN
cord-258416-1jrbu8ox	90	17	France	France	NNP
cord-258416-1jrbu8ox	90	18	Characterization	Characterization	NNP
cord-258416-1jrbu8ox	90	19	of	of	IN
cord-258416-1jrbu8ox	90	20	acute	acute	JJ
cord-258416-1jrbu8ox	90	21	acro	acro	JJ
cord-258416-1jrbu8ox	90	22	-	-	HYPH
cord-258416-1jrbu8ox	90	23	ischemic	ischemic	JJ
cord-258416-1jrbu8ox	90	24	lesions	lesion	NNS
cord-258416-1jrbu8ox	90	25	in	in	IN
cord-258416-1jrbu8ox	90	26	nonhospitalized	nonhospitalized	JJ
cord-258416-1jrbu8ox	90	27	patients	patient	NNS
cord-258416-1jrbu8ox	90	28	:	:	:
cord-258416-1jrbu8ox	90	29	a	a	DT
cord-258416-1jrbu8ox	90	30	case	case	NN
cord-258416-1jrbu8ox	90	31	series	series	NN
cord-258416-1jrbu8ox	90	32	of	of	IN
cord-258416-1jrbu8ox	90	33	132	132	CD
cord-258416-1jrbu8ox	90	34	patients	patient	NNS
cord-258416-1jrbu8ox	90	35	during	during	IN
cord-258416-1jrbu8ox	90	36	the	the	DT
cord-258416-1jrbu8ox	90	37	COVID-19	covid-19	JJ
cord-258416-1jrbu8ox	90	38	outbreak	outbreak	NN
cord-258416-1jrbu8ox	90	39	Coagulopathy	Coagulopathy	NNP
cord-258416-1jrbu8ox	90	40	and	and	CC
cord-258416-1jrbu8ox	90	41	antiphospholipid	antiphospholipid	NNP
cord-258416-1jrbu8ox	90	42	antibodies	antibody	NNS
cord-258416-1jrbu8ox	90	43	in	in	IN
cord-258416-1jrbu8ox	90	44	patients	patient	NNS
cord-258416-1jrbu8ox	90	45	with	with	IN
cord-258416-1jrbu8ox	90	46	Covid-19	Covid-19	NNP
cord-258416-1jrbu8ox	90	47	Viral	viral	JJ
cord-258416-1jrbu8ox	90	48	infections	infection	NNS
cord-258416-1jrbu8ox	90	49	and	and	CC
cord-258416-1jrbu8ox	90	50	antiphospholipid	antiphospholipid	NNP
cord-258416-1jrbu8ox	90	51	antibodies	antibody	NNS
cord-258416-1jrbu8ox	90	52	COVID-19	COVID-19	NNP
cord-258416-1jrbu8ox	90	53	can	can	MD
cord-258416-1jrbu8ox	90	54	present	present	VB
cord-258416-1jrbu8ox	90	55	with	with	IN
cord-258416-1jrbu8ox	90	56	a	a	DT
cord-258416-1jrbu8ox	90	57	rash	rash	NN
cord-258416-1jrbu8ox	90	58	and	and	CC
cord-258416-1jrbu8ox	90	59	be	be	VB
cord-258416-1jrbu8ox	90	60	mistaken	mistake	VBN
cord-258416-1jrbu8ox	90	61	for	for	IN
cord-258416-1jrbu8ox	90	62	dengue	dengue	NN
cord-258416-1jrbu8ox	90	63	Reply	Reply	NNP
cord-258416-1jrbu8ox	90	64	to	to	IN
cord-258416-1jrbu8ox	90	65	"	"	``
cord-258416-1jrbu8ox	90	66	COVID-19	COVID-19	NNP
cord-258416-1jrbu8ox	90	67	can	can	MD
cord-258416-1jrbu8ox	90	68	present	present	VB
cord-258416-1jrbu8ox	90	69	with	with	IN
cord-258416-1jrbu8ox	90	70	a	a	DT
cord-258416-1jrbu8ox	90	71	rash	rash	NN
cord-258416-1jrbu8ox	90	72	and	and	CC
cord-258416-1jrbu8ox	90	73	be	be	VB
cord-258416-1jrbu8ox	90	74	mistaken	mistake	VBN
cord-258416-1jrbu8ox	90	75	for	for	IN
cord-258416-1jrbu8ox	90	76	dengue	dengue	NN
cord-258416-1jrbu8ox	90	77	"	"	''
cord-258416-1jrbu8ox	90	78	:	:	:
cord-258416-1jrbu8ox	90	79	Petechial	Petechial	NNP
cord-258416-1jrbu8ox	90	80	rash	rash	NN
cord-258416-1jrbu8ox	90	81	in	in	IN
cord-258416-1jrbu8ox	90	82	a	a	DT
cord-258416-1jrbu8ox	90	83	patient	patient	NN
cord-258416-1jrbu8ox	90	84	with	with	IN
cord-258416-1jrbu8ox	90	85	COVID-19	covid-19	JJ
cord-258416-1jrbu8ox	90	86	infection	infection	NN
cord-258416-1jrbu8ox	91	1	A	a	DT
cord-258416-1jrbu8ox	91	2	dermatologic	dermatologic	JJ
cord-258416-1jrbu8ox	91	3	manifestation	manifestation	NN
cord-258416-1jrbu8ox	91	4	of	of	IN
cord-258416-1jrbu8ox	91	5	COVID-19	covid-19	JJ
cord-258416-1jrbu8ox	91	6	:	:	:
cord-258416-1jrbu8ox	91	7	transient	transient	JJ
cord-258416-1jrbu8ox	91	8	livedo	livedo	NN
cord-258416-1jrbu8ox	91	9	reticularis	reticularis	JJ
cord-258416-1jrbu8ox	91	10	Histopathological	Histopathological	NNP
cord-258416-1jrbu8ox	91	11	study	study	NN
cord-258416-1jrbu8ox	91	12	of	of	IN
cord-258416-1jrbu8ox	91	13	3	3	CD
cord-258416-1jrbu8ox	91	14	cases	case	NNS
cord-258416-1jrbu8ox	91	15	of	of	IN
cord-258416-1jrbu8ox	91	16	new	new	JJ
cord-258416-1jrbu8ox	91	17	coronavirus	coronavirus	NN
cord-258416-1jrbu8ox	91	18	pneumonia	pneumonia	NN
cord-258416-1jrbu8ox	91	19	(	(	-LRB-
cord-258416-1jrbu8ox	91	20	COVID-19	covid-19	VB
cord-258416-1jrbu8ox	91	21	)	)	-RRB-
cord-258416-1jrbu8ox	91	22	with	with	IN
cord-258416-1jrbu8ox	91	23	multi	multi	JJ
cord-258416-1jrbu8ox	91	24	-	-	JJ
cord-258416-1jrbu8ox	91	25	site	site	JJ
cord-258416-1jrbu8ox	91	26	puncture	puncture	NN
cord-258416-1jrbu8ox	91	27	Complement	complement	NN
cord-258416-1jrbu8ox	91	28	associated	associate	VBD
cord-258416-1jrbu8ox	91	29	microvascular	microvascular	JJ
cord-258416-1jrbu8ox	91	30	injury	injury	NN
cord-258416-1jrbu8ox	91	31	and	and	CC
cord-258416-1jrbu8ox	91	32	thrombosis	thrombosis	NN
cord-258416-1jrbu8ox	91	33	in	in	IN
cord-258416-1jrbu8ox	91	34	the	the	DT
cord-258416-1jrbu8ox	91	35	pathogenesis	pathogenesis	NN
cord-258416-1jrbu8ox	91	36	of	of	IN
cord-258416-1jrbu8ox	91	37	severe	severe	JJ
cord-258416-1jrbu8ox	91	38	COVID-19	covid-19	JJ
cord-258416-1jrbu8ox	91	39	infection	infection	NN
cord-258416-1jrbu8ox	91	40	:	:	:
cord-258416-1jrbu8ox	92	1	a	a	DT
cord-258416-1jrbu8ox	92	2	report	report	NN
cord-258416-1jrbu8ox	92	3	of	of	IN
cord-258416-1jrbu8ox	92	4	five	five	CD
cord-258416-1jrbu8ox	92	5	cases	case	NNS
cord-258416-1jrbu8ox	93	1	SARS	SARS	NNP
cord-258416-1jrbu8ox	93	2	-	-	HYPH
cord-258416-1jrbu8ox	93	3	COV-2	COV-2	NNP
cord-258416-1jrbu8ox	93	4	infection	infection	NN
cord-258416-1jrbu8ox	93	5	is	be	VBZ
cord-258416-1jrbu8ox	93	6	likely	likely	JJ
cord-258416-1jrbu8ox	93	7	to	to	TO
cord-258416-1jrbu8ox	93	8	be	be	VB
cord-258416-1jrbu8ox	93	9	androgen	androgen	NN
cord-258416-1jrbu8ox	93	10	mediated	mediate	VBN
cord-258416-1jrbu8ox	93	11	A	a	DT
cord-258416-1jrbu8ox	93	12	preliminary	preliminary	JJ
cord-258416-1jrbu8ox	93	13	observation	observation	NN
cord-258416-1jrbu8ox	93	14	:	:	:
cord-258416-1jrbu8ox	93	15	Male	male	JJ
cord-258416-1jrbu8ox	93	16	pattern	pattern	NN
cord-258416-1jrbu8ox	93	17	hair	hair	NN
cord-258416-1jrbu8ox	93	18	loss	loss	NN
cord-258416-1jrbu8ox	93	19	among	among	IN
cord-258416-1jrbu8ox	93	20	hospitalized	hospitalize	VBN
cord-258416-1jrbu8ox	93	21	COVID-19	covid-19	CD
cord-258416-1jrbu8ox	93	22	patients	patient	NNS
cord-258416-1jrbu8ox	93	23	in	in	IN
cord-258416-1jrbu8ox	93	24	Spain	Spain	NNP
cord-258416-1jrbu8ox	94	1	-A	-A	:
cord-258416-1jrbu8ox	94	2	potential	potential	JJ
cord-258416-1jrbu8ox	94	3	clue	clue	NN
cord-258416-1jrbu8ox	94	4	to	to	IN
cord-258416-1jrbu8ox	94	5	the	the	DT
cord-258416-1jrbu8ox	94	6	role	role	NN
cord-258416-1jrbu8ox	94	7	of	of	IN
cord-258416-1jrbu8ox	94	8	androgens	androgen	NNS
cord-258416-1jrbu8ox	94	9	in	in	IN
cord-258416-1jrbu8ox	94	10	COVID-19	covid-19	JJ
cord-258416-1jrbu8ox	94	11	severity	severity	NN
cord-258416-1jrbu8ox	94	12	What	what	WP
cord-258416-1jrbu8ox	94	13	does	do	VBZ
cord-258416-1jrbu8ox	94	14	androgenetic	androgenetic	JJ
cord-258416-1jrbu8ox	94	15	alopecia	alopecia	NNS
cord-258416-1jrbu8ox	94	16	have	have	VB
cord-258416-1jrbu8ox	94	17	to	to	TO
cord-258416-1jrbu8ox	94	18	do	do	VB
cord-258416-1jrbu8ox	94	19	with	with	IN
cord-258416-1jrbu8ox	94	20	COVID-19	covid-19	NN
cord-258416-1jrbu8ox	94	21	?	?	.
cord-258416-1jrbu8ox	95	1	An	an	DT
cord-258416-1jrbu8ox	95	2	insight	insight	NN
cord-258416-1jrbu8ox	95	3	into	into	IN
cord-258416-1jrbu8ox	95	4	a	a	DT
cord-258416-1jrbu8ox	95	5	potential	potential	JJ
cord-258416-1jrbu8ox	95	6	new	new	JJ
cord-258416-1jrbu8ox	95	7	therapy	therapy	NN
cord-258416-1jrbu8ox	95	8	Infants	infant	NNS
cord-258416-1jrbu8ox	95	9	Born	bear	VBN
cord-258416-1jrbu8ox	95	10	to	to	IN
cord-258416-1jrbu8ox	95	11	Mothers	mother	NNS
cord-258416-1jrbu8ox	95	12	With	with	IN
cord-258416-1jrbu8ox	95	13	a	a	DT
cord-258416-1jrbu8ox	95	14	New	New	NNP
cord-258416-1jrbu8ox	95	15	Coronavirus	Coronavirus	NNP
cord-258416-1jrbu8ox	95	16	(	(	-LRB-
cord-258416-1jrbu8ox	95	17	COVID-19	COVID-19	NNP
cord-258416-1jrbu8ox	95	18	)	)	-RRB-
cord-258416-1jrbu8ox	95	19	COVID-19	COVID-19	NNP
cord-258416-1jrbu8ox	95	20	and	and	CC
cord-258416-1jrbu8ox	95	21	Kawasaki	Kawasaki	NNP
cord-258416-1jrbu8ox	95	22	disease	disease	NN
cord-258416-1jrbu8ox	95	23	:	:	:
cord-258416-1jrbu8ox	96	1	novel	novel	JJ
cord-258416-1jrbu8ox	96	2	virus	virus	NN
cord-258416-1jrbu8ox	96	3	and	and	CC
cord-258416-1jrbu8ox	96	4	novel	novel	NN
cord-258416-1jrbu8ox	96	5	case	case	NN
cord-258416-1jrbu8ox	96	6	Chinese	chinese	JJ
cord-258416-1jrbu8ox	96	7	doctors	doctor	NNS
cord-258416-1jrbu8ox	96	8	'	'	POS
cord-258416-1jrbu8ox	96	9	skin	skin	NN
cord-258416-1jrbu8ox	96	10	turns	turn	VBZ
cord-258416-1jrbu8ox	96	11	dark	dark	JJ
cord-258416-1jrbu8ox	96	12	after	after	IN
cord-258416-1jrbu8ox	96	13	coronavirus	coronavirus	NN
cord-258416-1jrbu8ox	96	14	recovery	recovery	NN
cord-258416-1jrbu8ox	96	15	Classification	classification	NN
cord-258416-1jrbu8ox	96	16	of	of	IN
cord-258416-1jrbu8ox	96	17	the	the	DT
cord-258416-1jrbu8ox	96	18	cutaneous	cutaneous	JJ
cord-258416-1jrbu8ox	96	19	manifestations	manifestation	NNS
cord-258416-1jrbu8ox	96	20	of	of	IN
cord-258416-1jrbu8ox	96	21	COVID-19	COVID-19	NNP
cord-258416-1jrbu8ox	96	22	:	:	:
cord-258416-1jrbu8ox	96	23	a	a	DT
cord-258416-1jrbu8ox	96	24	rapid	rapid	JJ
cord-258416-1jrbu8ox	96	25	prospective	prospective	JJ
cord-258416-1jrbu8ox	96	26	nationwide	nationwide	JJ
cord-258416-1jrbu8ox	96	27	consensus	consensus	NN
cord-258416-1jrbu8ox	96	28	study	study	NN
cord-258416-1jrbu8ox	96	29	in	in	IN
cord-258416-1jrbu8ox	96	30	Spain	Spain	NNP
cord-258416-1jrbu8ox	96	31	with	with	IN
cord-258416-1jrbu8ox	96	32	375	375	CD
cord-258416-1jrbu8ox	96	33	cases	case	NNS
cord-258416-1jrbu8ox	97	1	The	the	DT
cord-258416-1jrbu8ox	97	2	AAD	AAD	NNP
cord-258416-1jrbu8ox	97	3	COVID-19	COVID-19	NNP
cord-258416-1jrbu8ox	97	4	Registry	Registry	NNP
cord-258416-1jrbu8ox	97	5	:	:	:
cord-258416-1jrbu8ox	97	6	Crowdsourcing	Crowdsourcing	NNP
cord-258416-1jrbu8ox	97	7	Dermatology	Dermatology	NNP
cord-258416-1jrbu8ox	97	8	in	in	IN
cord-258416-1jrbu8ox	97	9	the	the	DT
cord-258416-1jrbu8ox	97	10	Age	Age	NNP
cord-258416-1jrbu8ox	97	11	of	of	IN
cord-258416-1jrbu8ox	97	12	COVID-19	COVID-19	NNP